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1. Introduction. Sjögren’s Syndrome: Basic concepts. 
This syndrome was first described back in 1933 by Dr Henrik 
Samuel Conrad Sjögren as a chronic inflammation of both salivary 
and lachrymal glands, causing dry eye (keratoconjunctivitis sicca) 
and dry mouth (xerostomia). The Sjögren’s syndrome (SS) alters 
the glandular secretion process because of a lymphocytic 
infiltration in the gland tissues (Brennan et al, 2014) 
In those cases where the disease occurs by itself, the disorder is 
known as “primary Sjögren’s syndrome”. When the syndrome 
arises in relation to other autoimmune diseases (rheumatoid 
arthritis, erythematous lupus, scleroderma, mixed connective 
tissue disease, primary biliary cirrhosis, vasculitis, or active 
chronic hepatitis) is named “secondary Sjögren’s syndrome”. 
The world prevalence of SS is 1.40% (95%CI 1.02 – 1-92), 
affecting mostly women (3.8%, 95%CI 27 – 52). The prevalence is 
higher for elder age groups (≥55 years-old) (4.6; 95%CI 34 – 61). 
Secondary SS is also present in up to 30% of patients with 
immune-related rheumatic disease. The estimated incidence of SS 
rages from 3 to 6 cases/100,000 inhabitants/year (Reksten et al, 
2014). 
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1.1. Pathogenesis of Sjögren’s syndrome 
This disorder is characterised by a lymphocytic infiltration of 
exocrine glands in combination with an exaggerated response by 
B lymphocytes. Serologic tests of SS patients often show 
antibodies against unspecific antigens, like certain 
immunoglobulins (rheumatoid factors), and against extractable 
nuclear and cytoplasmic antigens (Ro/SS-A, La/SS-B) (Usuba et al, 
2014). 
The main type of cells infiltrating damaged exocrine glands are 
activated B- and T- lymphocytes, prevailing the latter in weaker 
lesions and the former in those more severe.  Regulatory T-cells, 
macrophages, and dendritic cells have also been involved in this 
process. 
The lymphocytes (apoptosis-resistant) send apoptosis signals to 
the epithelial glandular cells, and the epithelial and acinar cells 
contribute to this autoimmune course by expressing class-II major 
histocompatibility complex (MHC), co-stimulating molecules, and 
cell-membrane intracellular auto-antigens. These processes, in 
turn, send signals for lymphocytic activation. Besides, pro-
inflammatory and lymphotactic cytokines are erroneously 
produced which extend the autoimmune lesion and induce the 
formation of more complex ectopic germinative centres. This 
phenomenon occurs in up to 20% of the patients. The extension of 
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a immune response is due to the expression of innate immunity 
receptors, mainly TLR 3, 7 and 9 (Cornec et al (a,b), 2014). 
1.2. Autoimmunity mechanisms 
The body immune system is designed for preserving and avoiding 
damage to its own tissues, relying on three processes devoted to 
ensure a selective insensitivity to autoantigens:  
1. Autoantigen sequestration, rendering them not accessible for 
the immune system 
2. Selective insensitivity of concerned B- or T- lymphocytes 
3. Limitation of potential reactivity by regulatory mechanisms 
Alterations in these processes may favour the development of an 
autoimmune response (Cornec et al (a), 2014). Thus, different 
exogenous triggers (bacteria, virus, smoking habit…) may act by: 
Stimulation by superantigens: Substances of microbial origin able 
to stimulate a wide variety of T and B lymphocytes according to 
specific interactions with selected families of receptors, no-matter 
their antigenic specificity. Autoimmunity may arise if the T and B 
lymphocytes reactive to autoantigens express these receptors 
(Cornec et al (b),2014).  
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Molecular mimicry: Cross reactivity between a microbial product 
and a self-antigen that can induce activation of autoreactive 
lymphocytes. 
Microbial adjuvants: Infectious microorganisms may overcome 
the self-tolerance because of their molecules with a quasi-
adjuvant effect on the immune system, able to stimulate immune 
cells toll-like receptors. (Fujinami et al. 2006) 
1.3. Clinical manifestations of the Sjögren’s syndrome 
This multiple, multi-organ exocrinopathy may arise as an 
ophthalmic and/or mucocutaneous alteration which can also be 
associated to a series of different extraglandular conditions, like 
musculoskeletal, digestive, pulmonary, haematological and 
neurological disorders (Lenopoli et ak, 2014). 
1.3.1. Ophthalmic  manifestations 
As a result of keratoconjunctivitis sicca, patients may experience 
sensation of foreign body in the eyes, stinging, photosensitivity, 
eyestrain, impaired visual acuity, and also certain periods of 
watering. Human tears form a film over the eyes to protect them 
from irritation while keeping them moisturised and lubricated. A 
decrease in this secretion may cause, in severe cases, corneal 
ulcerations and –rarely- perforations. Another consequence of 
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xerophtalmia may also be conjunctivitis due to colonisation by 
Staphylococcus aureus. 
1.3.2. Oral manifestations  
 As a result of xerostomia, patients may experiment halitosis, 
difficulties for chewing dry foods, pain, and loss of retention of 
their removable dentures (Lopez-Jornet J, 2004). 
Dry mucosa with roughness and/or fissures is frequently seen at 
more advanced stages of the disease. Tooth decay is also a 
common finding, and these lesions progress rapidly and affect 
unusual tooth sites (molar cusps, incisal borders, and teeth necks). 
The tongue surface shows depapilated, reddish, areas with a 
lobulated appearance (Jensen et al, 2014). 
Candida colonisation is also often linked to SS. These patients 
habitually experience difficulties for speaking because their 
tongue “sticks” to the palate due to the absence of saliva (Table 1). 
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Table 1. Signs and symptoms related to hyposalivation, according 
to the criteria by López-Jornet (2004). 
Oral functional symptomatology
- Dry mouth sensation
- Difficulty to keep the mouth moisturised (need to drink water 
frequently) 
- Difficulties for speaking (dysphonia), swallowing (dysphagia), and 
chewing (particularly dry food) 
- Dysgeusia (taste changes) 
- Oral discomfort (lack of oral lubrication) 
- Burning mouth 
- Need to get up for drinking water (difficulty for sleeping) 
- Changes in the nutritional pattern 
Organic oral symptomatology
- Tooth decay: number, extension, and site
- Gingivitis and periodontal disease 
- Halitosis 
- Prosthodontic problems (poor denture adaptation) 
- Mucous problems: 
 - Atrophy, fissures and ulceration 
 - Changes in the lips and corners of the mouth 
 - Dryness, erythema, pain (burning mouth), loss of glow 
 - Traumatic lesions 
 - Increased sensitivity to irritating factors: tobacco, alcohol, etc 
Related extra-oral lesions
- Eyes: blurred vision, gritty feeling, need to use artificial tears 
- Genitals: dryness, itching, burning sensation, recurrent vaginitis 
- Skin: peeling, cracking 
- ENT: nasal dryness 
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1.3.3. Systemic disorders in Sjögren’s syndrome 
The Sjögren’s syndrome is a systemic disease whose main and 
more suggestive symptoms are those related to the sicca 
syndrome. However, and taking into account the whole 
pathochronia of the disease, a number of organs and tissues can 
also be affected resulting in clinical manifestations in these 
patients (Lenopoli et al, 2014; Kramer et al, 2014).  
1.3.3.1. Musculoskeletal alterations 
Despite that about 20% of patients with rheumatoid arthritis elicit 
a secondary SS, a high proportion of patients suffering from 
primary Sjögren’s syndrome experience musculoskeletal 
alterations, typically in small joints (Carsons, 2001; Kassan et al. 
2004). Approximately half of these patients suffer arthralgias and, 
less frequently, myalgias. Deformity of small joints and non-
erosive arthritis, close to that in erythematous systemic lupus, are 
less frequent findings. 
1.3.3.2. Dermatologic alterations 
The main cutaneous manifestation of this syndrome is skin 
dryness, found in about 50% of SS patients, sometimes 
accompanied by itching, excoriations, and superinfections. 
(Kassan et al.2004) 
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Another skin alterations in these patients include ulcerations, a 
hypothetical association to hypergammaglobulinemic purpura or 
to leukocytoclastic vasculitis. Vasculitis in SS patients can range 
from a cutaneously localised form to a systemic necrotizing 
vasculitis. It is also important to ensure a correct differential 
diagnosis with systemic erythematous lupus and with 
schlerodermia, because of some common findings shared with 
these entities. About 30% of SS patients may also present a low-
intensity Raynaud phenomenon. 
1.3.3.2. Pulmonary alterations 
The main respiratory symptom identified among patients 
suffering from primary Sjögren’s syndrome is cough usually 
resulting from dryness of the bronchial tree (Carsons, 2001). 
Radiological examination of these patients may often display 
images resembling “ground glass”, reticular pattern and 
honeycomb, affecting mostly the lower lobules. 
1.3.3.3. Renal alterations 
Renal alterations are frequent extraglandular manifestations of 
primary Sjögren’s syndrome. Tubular involvement may result 
from interstitial lymphocytic infiltrate, with interstitial fibrosis 
and tubular atrophy or glomerular affectation. 
1. Introduction. Sjögren’s Syndrome: Basic concepts 
23 
Tubulointerstitial nephritis is the most common renal affectation, 
usually characterised by distal renal tubular acidosis as a 
consequence of the tubulointerstitial inflammatory infiltrate. 
(Kassan et al.2004) 
Despite the existing reports, nephrocalcinosis, nephrogenic 
diabetes insipidus, proximal tubular renal tubular acidosis, or 
Fanconi syndrome are infrequent situations. In the absence of 
treatment, SS may lead to the formation of stones and cause renal 
failure. Regarding to symptoms of tubular acidosis, early signs 
would be hypokalemia and hyperchloremic acidosis. 
1.3.3.5. Gastrointestinal alterations 
Esophageal dysmotility, as a consequence of xerostomia, is a 
common finding amongst these patients, who frequently report 
gastro-oesophagal  and laryngopahryngeal reflux too. 
The acids and the enzymatic activity in perioral tissues may cause 
dysphonia, chronic cough, sore throat, mucus in the throat, tooth 
decay, and they may even induce carcinogenic changes in the 
larynx. Although infrequent in SS, pancreatic involvement 
includes pancreatitis and pancreatic insufficiency. The symptoms 
reported by these patients can embrace episodes of abdominal 
pain and/or symptoms related to intestinal mal-absorption. 
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1.3.3.6. Liver alterations 
Liver alterations caused by the Sjögren’s syndrome are rarely 
seen, although a thorough differential diagnosis with primary 
biliary cirrhosis is mandatory. Both disorders share the same 
pathogenic autoimmune mechanisms, but SS patients show anti-
Ro and anti-La antibodies whereas in primary biliary cirrhosis the 
main specific auto-antibody is the anti-mitochondrial antibody. 
1.3.3.7. Gynaecologic and obstetric alterations 
A number of dyspareunia cases have been reported, due to 
alterations in the lubrication in premenopausal women suffering 
from primary Sjögren’s syndrome. Other described gynaecologic 
problems include vaginal dryness, endometriosis, and episodes of 
amenorrhoea and menorrhagia/metrorrhagia. 
1.3.3.8. Neurologic alterations 
Probably, these are the most frequent systemic alterations in SS 
patients. Despite it is mostly a peripheral neuropathy, some 
reports have described central nervous system disturbances such 
as optic neuropathy, seizures, cognitive dysfunctions, and multiple 
sclerosis-like manifestations. Sjögren’s syndrome patients may 
also experience neuropathic pain involving back, extremities, or 
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face. One of the most frequent cranial neuropathies among SS 
patients is the trigeminal neuralgia. 
1.3.3.9. Lymphoma 
Primary Sjögren’s syndrome patients are at higher risk for 
lymphoma, and about 5% to 10% of these patients have 
developed this disease. The most frequent type of lymphoma is  
the non-Hodgkin one, partly originated from B cells, which can 
involve extranodal sites such as salivary glands, gastrointestinal 
tract, lungs, and the thyroid gland. Signs of lymphoproliferation 
include an increase on the size of salivary glands, 
lymphadenopathy, splenomegaly, and lung infiltrate. A serological 
follow-up is recommended. As a result of the monoclonal protein, 
leukopenia and anaemia, and a loss of previously present specific 
autoantibodies have been associated with the development of 
lymphoma. Moreover, the presence of signs like enlargement of 
the salivary glands and/or lymphadenopathy, without the typical 
lymphoid pathological findings is known as “pseudo-lymphoma” 
(Carsons, 2001; Kassan 2004). 
1.4. Diagnosis 
Different protocols for the diagnosis of Sjögren’s syndrome have 
been agreed through the time (Goules et al, 2014; Fazaa et al, 
2014; Theander et al, 2013; Shiboski, 2012 ): 
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1.4.1. Copenhagen criteria 
These criteria dates back to 1976 and groups a series of diagnostic 
tests based upon objective signs rather than on related symptoms. 
(Manthorpe et al.,1986) These tests mainly relied on the diagnosis 
of keratoconjuctivitis and xerostomia. These criteria distinguished 
the primary Sjögren’s syndrome (defined as the simultaneous 
presence of keratoconjunctivitis and xerostomia in patients 
without any chronic inflammatory connective tissue disorder) 
from the secondary SS, identified in patients with an associated 
chronic inflammatory alteration. 
For the diagnosis of keratoconjunctivitis  sicca (KCS), the 
following tests were suggested: 
- Schimmer-I test (results ≤10mm/5min) 
- Tear film break-up time (≤10 s) 
- Van Bijsterverd scale (score ≥4 points in a 0-9 scale) 
For the diagnosis of xerostomia: 
- Non-stimulated sialometry (≤1.5 ml/15 min) 
- Salivary gland scintigraphy  
- Biopsy of minor salivary glands in the lower lip 
1.4.2. Japanese committee of experts for SS diagnosis 
The agreement reached by this group of experts included 
ophthalmologic and oral examinations (as recommended by the 
1. Introduction. Sjögren’s Syndrome: Basic concepts 
27 
Copenhagen group), together with pathological examination and 
specific serology. Diagnosis of Sjögren’s syndrome was considered 
positive when the case met at least two of the four criteria. 
(Gomes et al (a) 2012). 
1.4.3. Study group on diagnostic criteria for Sjögren’s syndrome 
In 1988, with the intention of validating and generalising a 
reliable diagnostic system for SS, a group of 29 experts from 12 
countries (11 European nations and Israel) designed a study 
protocol divided into two stages: 
Stage I: Questionnaires on ocular and oral manifestations of the 
disease (13 questionnaires on ophthalmologic manifestations, and 
7 about oral ones). These forms were filled by 15 patients 
clinically diagnosed as primary SS, and by another 15 subjects in a 
control group. 
Stage II: A set of diagnostic tests were proposed. These tests 
would be validated by later studies, as would the procedures for 
undertaking them. The suggested tests for ophthalmic 
manifestations were: 
- Schirmer-I test. 
- Rose Bengal scale 
- Tear film break-up time 
- Lactoferrin levels in lachrymal fluid 
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For assessing oral manifestations, the tests proposed included: 
- Non-stimulated and stimulated saliva secretion levels 
- Minor salivary gland biopsy 
-Parotid sialography 
- Salivary gland scintigraphy 
Serological study would consider the levels of gamma globulin, 
anti-nuclear antibodies, rheumatoid factors and anti-ENA. 
Every physician collaborating in the study received information 
about the parameters of the diagnostic tests, as well as about the 
possible signs and symptoms of the disease. 
Each centre returned clinical and serological information from a 
total of 40 patients: 10 primary SS (group I), 10 secondary SS 
(group II), 10 patients with connective tissue diseases without SS 
(group III), and 10 control patients (group IV). The exclusion 
criteria considered were the presence of a pre-existent lymphoma, 
sarcoidosis, AIDS, and graft-versus-host disease. 
Amongst the most remarkable results of this study was the finding 
that the questionnaires with 3 questions about dry mouth and 3 
questions about dry eyes were the most predictive for 
xerophtalmia and xerostomia in primary SS. 
Regarding to ophthalmological tests, the Schirmer-I test seems to 
keep a good relationship between sensitivity and specificity, 
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whereas the Rose Bengal scale was by far the most specific test. 
The tear film break-up time scored the highest sensitivity but a 
low specificity. The determination of lactoferrin levels in 
lachrymal fluid resulted inconclusive for SS diagnosis. 
When assessing salivary tests, the stimulated salivary flow was 
the only test yielding irrelevant results. Salivary gland biopsy 
showed a good relationship between sensitivity and specificity for 
SS diagnosis. The anti-Ro/SS-A and anti-La/SS-B antibodies 
scored high specificity but low sensitivity, whereas the 
rheumatoid factor and the anti-nuclear antibodies (ENA) elicited 
an acceptable specificity. 
Taking into account the results of the above mentioned 
investigation, the Study Group on Diagnostic Criteria for Sjögren’s 
syndrome reached an agreement about 6 criteria for diagnosing 
SS, establishing that the presence of 3 criteria was required for 
diagnosing a probable SS, and the existence of 4 criteria and anti-
Ro/SS-A and anti-La/SS-B for a definitive diagnosis of Sjögren’s 
syndrome  (Vitali et al. 1996)(Table 2). 
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Table 2. Classification criteria for Sjögren's syndrome by the -
European Consensus Group. 
European  criteria for Sjögren’s 
síndrome) 
SS criteria:
4/6 
3 /4 (objective criteria) 
1. Ophthalmic symptoms Dry-eye sensation for 3 months 
Gritty feeling 
Need for artificial tears >3 times/day 
2. Oral symptoms Dry-mouth sensation for 3 months 
Salivary gland enlargement 
Need for a drink to swallow down 
3. Ophthalmic signs
4. Glandular biopsy
  (Parotid echography) 
5. Objective alteration of 
glandular physiology 
Sialometry
Parotid sialography 
Parotid gammagraphy 
6. Auto-antibodies Anti Ro/SA or Anti La/SSb
 
These European criteria for SS diagnosis were widely accepted by 
the scientific community and used in a great number of 
extensively referenced clinical studies since their publication. In 
spite this fact, and aiming at unifying criteria and acceptation of 
the European classification criteria, the SS Foundation promoted a 
new study group integrating the European and the American 
working groups. As a result, a series of meetings were held 
between 1998 and 2000, where the criteria were agreed. It was 
also established that patients had to meet 4 out the 6 criteria for 
reaching a definitive diagnosis of SS, although two of these tests 
had to be the presence of inflammation in the minor salivary gland 
biopsy (focus score ≥1), and positive serology (anti-Ro/SS-A 
and/or anti-La/SS-B). 
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As a result of this new consensus, some modifications were made 
on the exclusion criteria concerning hepatitis C patients, AIDS, 
pre-existent lymphoma, graft-versus-host disease, patients 
receiving head and neck radiotherapy, and those under treatment 
with anticholinergic drugs.(Vitali et al., 2002) 
Much more recently, and following the idea of removing 
subjective issues and considering only objective tests, new 
standards have been developed for definitive SS diagnosis, which 
require a positive serology (anti-SSA and/or SSB or positive 
rheumatic factor /ANAs), presence of focal lymphocytic 
sialadenitis (>1 per 4 mm2 of glandular tissue) an positive Rose 
Bengal staining (ocular staining score <3) (Shiboski et al. 2012) 
(Table 3). 
Table 3. Comparative between AESG and American criteria. 
AESG, 2002 American criteria, 2012
European Study Group, 1988 Serum markers:
SSA (+) and/or SSB (+) 
Or 
Rheumatoid factor (+) / ANAs 
(>1:320) 
American-European Study Group, 
2002 
Focal lymphocytic sialadenitis (>1 
focus) 
4/6 Rose Bengal >3
Exclusion criteria:
Head & Neck radiotherapy 
Hepatitis C 
AIDS 
Pre-existent lymphoma 
Graft-vs.-host disease 
Anticholinergic medications 
Standardised measurements based 
upon objective criteria 
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1.5. Lip biopsy for the diagnosis of Sjögren’s syndrome 
Glandular biopsy is a barely cumbersome surgical procedure that 
has demonstrated relevant contributions to the diagnosis of SS, as 
well as other connective tissue disorders, amyloidosis, 
sarcoidosis, or neonatal hemochromatosis. The analysis of lip 
glandular tissue has received more support than the study of 
major salivary gland tissue (parotid) or glandular tissue from the 
palate (Ton et al, 2009). 
This technique has proved high sensitivity (78.811.2) and 
specificity (88.111.7) together with high positive (87.6 9.5) and 
negative (79.016.9) predictive values. Conversely, substantial 
morbidity (pain, bruising, inflammation, transient difficulties for 
speaking and/or eating, bleeding, and alterations of cicatrisation) 
has been reported. Long-lasting neurological alterations (changes 
in lip sensitivity) may occur in up to 6% of patients. Regardless of 
these problems, there is a remarkable lack of standardisation of 
the surgical procedure: while some research groups recommend 
linear, circular, or elliptical incisions following parallel, oblique, or 
vertical directions to the fibres of the orbital muscle of the lips, 
other researches support the use of circular scalpels (punch) 
instead of the conventional one. Some different procedures for lip 
stabilisation have also been described to ease the biopsy 
technique (Risselada et al, 2014). 
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Anyhow, and because of the surgical nature of the procedures and 
its potential complications, the search for alternative, non-
invasive, complementary procedures for SS diagnosis continues 
(eg: sialochemistry, sialography, glandular ultrasonography) 
(Carotti et al, 2014; Kim et al, 2014) 
The chemical analysis of the saliva from SS patients has shown an 
increase of albumin levels due to inflammation and a high amount 
of inorganic components. Besides, antibodies anti-Ro/SSA and 
anti-La/SSB are more frequently found. 
Ultrasonography has also demonstrated a good correlation with 
sialography. This finding seems to suggest that this procedure 
may be potentially useful for a non-invasive diagnosis. 
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3. Justification 
Lip salivary gland biopsy has proved a high diagnostic yield and 
great validity for the diagnosis of Sjögren’s syndrome, even when 
dealing with unspecific clinical pictures with negative serology. 
Despite these clear advantages and the morbidity associated to 
the procedure, such as occasional sever neurological 
complications, there is no standard technique for undertaking lip 
biopsies. 
Currently, there are different surgical approaches for harvesting 
glandular tissue from the inner side of the lip, characterised by the 
size, orientation, and type of the incision as well as by the biopsy 
site. 
Unfortunately, the number of studies comparing the existing 
techniques is scarce and their conclusions are limited by the 
frequently poor description of the surgical procedures and by the 
vague categorisation of the associated complications. Besides, a 
unique study, methodologically weak, has undertaken a narrative 
review of the morbidity related to the surgical procedure with 
equivocal results. 
The aforementioned circumstances highlight the need for a 
quantitative, systematic study of the complications associated to 
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minor salivary gland biopsy, involving both the techniques and 
the instruments employed for this purpose. 
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4. Aims 
1. To systematically review and assess the existing literature for 
identifying the most suitable surgical technique for lip biopsy in 
terms of number and severity of neurological complications in 
patients suspicious for Sjögren’s syndrome. 
2. To undertake a pilot study on the use of circular scalpels for 
Sjögren’s syndrome diagnostic biopsies and to analyse the 
features of the samples harvested, as well as to design ancillary 
instruments with a potential for minimising the morbidity of the 
procedure. 
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5. Neurologic adverse events related to lip biopsy 
in patients suspicious for Sjögren’s syndrome: A 
systematic review and prevalence meta-analysis. 
Abstract 
Objectives: To compare the prevalence of neurological 
complications related to lip biopsy for Sjögren's Sindrome 
diagnosis using conventional versus, minimally invasive 
techniques. 
Methods: Systematic review and prevalence meta-analysis using 
the search strategy: ((“salivary gland biopsy” OR “labial biopsy” 
OR “lip biopsy”) AND (“Sjögren”)) in Medline, Embase and 
Proceedings web of science databases. 
Studies were selected if they included original data for minor 
salivary gland biopsy, sample size, exposure of interest (tecnique 
description), number of complications and number of affected 
patients. The prevalence of total and permanent neurological 
adverse effects was calculated. Both fixed-effects and random-
effects pooled estimates were assessed. Heterogeneity was 
calculated using an adaptation of the DerSimonian and Laird Q 
test. 
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Results: 16 papers were selected for the study. In the minimally 
invasive group (n=3), the pooled prevalence of total adverse 
events is almost 4 times higher than that in the linear incision 
group (n=12) (4.73% vs. 1.20%). On the contrary, the pooled 
prevalence of the permanent or potentially permanent 
neurological adverse events is 8.5 times lower in the minimally 
invasive technique group than in group of studies using linear 
incisions (0.17% vs. 1.45%). 
Conclusions: With the limitations intrinsic to the potential biases 
in the studies included in this meta-analysis, we conclude that 
minimally invasive lip biopsy technique for Sjögren's syndrome 
diagnosis induces less permanent neurological complications than 
conventional approaches with large linear incisions in the lower 
lip. 
Keywords: Sjögren’s syndrome; lip biopsy; minor salivary gland; 
diagnosis; adverse events; complications; neural damage. 
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Introduction 
Since Chisholm & Mason [1] described minor salivary gland 
biopsy (MSGB) as a valuable investigative procedure in Sjögren’s 
syndrome (SS) and established standardized criteria to assess 
inflammation, a number of surgical techniques have been 
suggested to harvest minor salivary glands for SS diagnosis. 
Focal sialadenitis (with a focus score ≥1) in minor salivary glands 
is one of the six requirements established for SS diagnosis [2]. 
This criterion has become more important as a recent consensus 
limits the definition of SS case to objective criteria only, and 
therefore two out of this three criteria would then be required: 
positive serum anti-SSa and or SSB; ocular staining score >3; and 
presence of focal sialadenitis with a focus score >1 per 4 mm2 of 
glandular tissue [3]. 
The value of MSGB for SS diagnosis is supported by high 
sensitivity (Mean (SD) 78.8 (11.2)) and specificity (88.1 (11.7)) 
values [2], reinforced by a good diagnostic confidence (positive 
predictive value: 87.6 (9.5); negative predictive value: 79.0 
(16.9)). This diagnostic value can be augmented by evaluating the 
cumulative focus score using a multilevel approach, assessing 
different section levels of the sampled glandular tissue cut at least 
at 200μm apart [4]. Thus, MSGB can be particularly useful for 
suspected SS patients with inconclusive clinical findings and 
negative anti-Ro/la serology [5, 6]. 
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A number of mediate and immediate surgical complications (pain, 
bruising, bleeding, wound infection) have been described for 
MSGB, but lip numbness has been found to be the only persistent 
complication and it is reported to occur in up to 6% of all MSGB 
[7-9]. Several techniques for lip MSGB have been proposed with a 
variety of incisions differing in shape (elliptical, circular, linear), 
orientation (vertical, oblique, parallel) and length (1mm to 3 cm), 
but no comparative studies on the advantages of a particular type 
in terms of postoperative morbidity could be retrieved [7,9-19]. 
The high diagnostic performance of MSGB demands an adequate 
surgical technique to ensure correct and sufficient sampling of 
glandular tissue with low related morbidity. Technique selection 
is hindered by the absence of comparative studies and the limited 
validity of the sole comprehensive review on the topic identified 
in the literature, due to the poor definition and vague 
categorization of the surgical complications [11]. These 
circumstances seem to justify the need for a systematic review 
and meta-analysis aimed at assessing the prevalence of 
neurological complications related to lip biopsy. The aim of this 
investigation was to compare the pooled prevalence of 
neurological adverse events induced by lip biopsy for SS diagnosis 
(minimally invasive technique versus linear incisions ≥5 mm). 
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Methods and materials 
Methods of analysis and inclusion criteria were defined in a 
protocol to ensure homogeneous criteria amongst all co-authors 
during the investigation. This protocol was initially conceived to 
record all post-biopsy adverse events described in the literature, 
but it was restricted later on during the study to permanent 
neurological adverse events. 
A systematic search was undertaken in June 2013 at MEDLINE, 
Embase, and Proceedings Web of Science (Conference 
proceedings citation index-Science (CPCI-S)). The search strategy 
was : ((“salivary gland biopsy” OR “labial biopsy” OR “lip biopsy”) 
AND (“Sjögren”)), both in medical subject headings (MeSH) and in 
freetext words. This search strategy was independently reviewed 
and discussed by all authors.  
This search was supplemented with an additional handsearch [20] 
performed at our Institution`s library catalogue, considering both 
books and relevant journals, including Annals of the Rheumatic 
Diseases, Arthritis & Rheumatism, Arthritis Research & Therapy, 
Osteoarthritis and Cartilage, Rheumatology, and the reference 
lists of the papers retrieved from the aforementioned databases 
(Fig 1). 
All references identified for computerized databases were 
manually retrieved. 
Studies were included if they fulfilled the following criteria: 
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I.  Included original data from MSGB performed for SS diagnosis 
II.  Included the sample size and the exposure of interest in the 
study: detailed description of the technique(s) for MSGB. 
III.  Assessed the presence or absence of neurological 
complications (lip numbness) and number of affected 
patients. 
Data were retrieved by two investigators in an unblinded 
standardized manner, using a custom-made extraction sheet. 
Disagreements between investigators were resolved by 
consensus.  
The percentage of technique-related neurological complications 
was again independently recorded by the reviewers and, in case 
this information was not detailed in the study, lower lip numbness 
was considered as persistent/permanent when lasting ≥6 months 
after the biopsy procedure. 
Quality assessment 
We assessed study quality by use of a five-point binary scale (0/1) 
that we specifically developed for this study. The scale is based on 
STROBE guidelines for reporting observational studies [21]. 
Throughout this assessment, when the information on a specific 
item was not provided by the authors, we graded this item as “0”. 
The quality scoring was independently undertaken by two 
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researchers (JS & BT). The first item assessed was whether post-
biopsy complications were a primary or specific objective of the 
reported investigation or were considered in a pre-specified 
hypothesis; in this case, a score of 1 was allocated. The second 
item assessed was the study design (one point to clearly described 
prospective designs). The third item assessed was the setting of 
the study (one point was given if the paper adequately described 
both the surgical scenario and data collection procedures). The 
fourth item assessed the follow-up time after surgery (one point if 
follow-up dates or dates at which the outcome events occurred or 
at which the outcomes were present). The last item concerned 
descriptive data on one important confounder: the number of 
glands harvested (1 point if the number of glands obtained is 
detailed in the paper). 
Data synthesis and analysis 
The concept of “minimally invasive techniques” gathers those 
techniques for MSGB consisting of multiple 2-3 mm incisions on 
the buccal side of the lip to collect the glandular tissue using a 
forceps. Punch techniques are not included within this group 
[9,10,13,18]. Another group of studies could be defined by those 
reports harvesting glandular tissue from the lower lip by means of 
a single, linear, ≥5 cm incision. 
For each study we computed the prevalence of total neurological 
adverse events and that of neurological permanent or potentially 
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permanent adverse events by dividing the number of events by 
the sample size of the study. We then weighted the study-specific 
prevalence by the inverse of their variance to compute a pooled 
prevalence and its 95% confidence interval. 
We calculated both fixed-effects and random-effects pooled 
estimates but used and report the latter when heterogeneity was 
present, as the random-effects model is generally thought to give 
more reliable results than the fixed-effects model, including a 
more conservative (wider) CI, when the studies being considered 
show a considerable degree of heterogeneity. In our study, this 
issue is particularly relevant as, in general, the number of events 
is low and in some studies the resulting prevalence is 0. Therefore, 
instead of using the traditional asymptotic method in order to 
obtain an estimate of the variance, inadequate in our setting, we 
use the exact method proposed by Newcombe and Altman [22]. 
To check for heterogeneity, we used a version adapted to small 
samples of the DerSimonian and Laird Q test, and to quantify this 
heterogeneity we calculated the proportion of the total variance 
due to between-study variance (Ri statistic) [23]. All analyses 
were performed with the software HEpiMA® version 2.1.3 [24]. 
Results 
The aforementioned systematic searches identified 342 single 
papers whose abstracts were reviewed for contents relevant to 
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the topic of this systematic review, and 301 of them were 
subsequently excluded. A total of 41 papers were then retrieved 
and reviewed, and seven of them were also excluded because their 
information was not useful for this study. 
The remaining 34 papers were checked according to the 
inclusion/exclusion criteria of the present review: 
Two papers were excluded because of double publication: the 
same information was published in more than one paper by 
Caporali et al [9, 25] and López-Amado et al. [26, 27]. Thus, one 
reference by each research group was considered in the study 
[9,27]. 
Two papers performed MSGB for indications other than diagnosis 
of SS [28,29]. 
Three manuscripts report inadequate descriptions of the surgical 
technique [17,30,31]. 
Nine articles report on the surgical technique, but not on its 
related complications [18, 32-39].  
A manuscript included only generic information on the surgical 
complication of MSGB [40].  
A report did not adequately described the size of the sample 
studied [19]. 
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So, 16 articles were finally selected to enter the systematic review, 
two of them report additional information on the same series of 
cases [8, 49]. (Fig 1). 
Only three of these reports describe neurological complications 
after lip MSGB in the context of a systematized data collection on 
both immediate (<24h) postoperative complications (bleeding, 
fainting, tachycardia, and bruising) and mediate adverse    events 
(pain, inflammation, suture dehiscence, infection, and granuloma 
or cheloid scarring) [9,10,12]. Three case series with larger 
sample sizes [9,10,13] describe minimally invasive lip biopsy 
techniques, and report neurological complications in a range from 
0 to 11.73%, although permanent hypoesthesias account for not 
more than 0.22% [9]. In contrast, twelve descriptive studies 
performing biopsies using 5 mm to 30 mm long linear incisions 
using a scalpel [8] with or without a chalazion forceps, report 
neurological complications in a range from 0 to 5.7% which 
remained after six months.  
Table 1 presents the characteristics of the studies included in this 
meta-analysis. Four studies did not provide information on 
permanent neurological adverse events and were excluded from 
this specific calculation. Their patients were not considered for 
calculating the pooled prevalence. 
High quality studies yielded a pooled prevalence that was 3 times 
as high as the pooled prevalence of low quality studies. Both 
estimates showed large heterogeneity. 
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Table 2 shows the pooled prevalence for each biopsy technique. 
Heterogeneity between studies was low, except for total adverse 
events in the minimally invasive technique: in this group the 
random effects pooled prevalence is then a more germane 
measure than that of the fixed effects model. In the minimally 
invasive group, the pooled prevalence of total adverse events is 
almost 4 times higher than that in the linear incision group 
(4.73% vs. 1.20 %). On the contrary, the pooled prevalence of the 
permanent or potentially permanent neurological adverse events 
is 8.5 times lower in the minimally invasive technique group than 
in the group of studies using linear incisions (0.17% vs. 1.45%). 
Moreover, studies performing linear incisional biopsies report 
lower percentages of complications in case series with high 
proportion (≥50%) of chronic saladenitis (1.01 vs 1.59). When 
studies perfoming linear incisional techniques were stratified by 
quality, those papers with high scores (Qs≥3) report a higher 
percentage of permanent neurological adverse events (2.50 vs 
0.82) (Table 2). 
Discussion 
Our study shows that, apparently, minimally invasive biopsy 
techniques are safer than conventional incisional approaches. 
No clinical trials focused on the aims of this meta-analysis could 
be retrieved. All reports considered in this systematic review are 
cases series without missing patients for follow-up, so a selection 
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bias is improbable. Alternatively, there is a potential for 
information bias as only three studies describe systematized 
procedures for recording information on immediate and mediate 
complications [9.10,12] and only one investigation employed a 
structured questionnaire with open and closed questions [9]. 
There also is an evident lack of consensus on the definition and 
classification of postoperative complications by severity [41] 
which may have facilitated inaccuracies and omissions during 
data collection. Very few studies provided information on 
confounding factors [12,42], such as corticosteroid therapy, 
radiotherapy, tobacco consumption, clinical setting (inpatient vs. 
outpatient), or chronic sialadenitis rate (table 2), which may 
influence post-biopsy complications [1,8,10,12,13,17,43]. In fact, 
only one investigation [12] made an attempt to address this issue 
during data analysis by stratifying the results by the use of 
sutures, and concluded it made no difference in terms of 
frequency and type of complications. This observed lack of control 
for confounding factors may hamper internal validity of the 
reports included in this meta-analysis, as high quality studies 
detect higher percentages of neurological complications (table 2). 
Minor salivary glands in the lower lip are distributed into 1 to 3 
layers of discrete gland cluster, mainly in the cuspid-premolar 
area [44]. The fact that minimally invasive techniques harvest 
only the more superficial glands would explicate the little risk of 
damaging the sensory nerves [13] and the lower prevalence of 
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permanent neurological complications. However, the need for 
multiple, small-sized, incisions and the proximity of nerve endings 
to the glands may explain the presence of postoperative transient 
lip hypoesthesias. Conventional techniques require larger 
incisions and dissection of the wound borders to frequently 
retrieve glands from deeper layers in the lip, where nerve fibres 
and glandular tissue are closely related, which may well explain 
the higher prevalence of permanent lip hypoesthesias in this 
group. 
Both approaches permit the fulfilment of SS diagnostic 
requirements –retrieval of at least five minor salivary glands 
[45,46]- in a minimal operative time [18,47], and both share 
common shortcomings: harvest similar percentages of fatty and 
fibro-muscular tissues and comparable numbers of biopsies 
resulting in insufficient amount of glandular tissue [7,10]. 
Two of the studies included in the meta-analysis did not report 
neurological morbidity after sublingual salivary gland biopsy 
[15,48], whereas another two studies found neither sensory nor 
motor nerve loss related to parotid gland biopsy for SS diagnosis 
[7,47]. These comparative studies seem to suggest that both 
procedures –sublingual and parotid biopsy- have a diagnostic 
potential for SS comparable to MSGB, but they may offer minor 
postoperative morbidity. Alternatively, MSGB have proved to be 
safe, simple, and suitable to extensive routine application in 
outpatient –internal medicine and rheumatology- settings [7,9]. 
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Despite techniques removing labial mucosa together with its 
attached glands have been discouraged because of the potential 
for neurological damage [16], a research group has recommended 
the use of a punch (4 mm diameter) for taking biopsies from the 
inner side of the lower lip. This paper described only 4% of 
transient numbness in a series of 50 patients with unknown 
follow-up periods [17]. This approach implies retrieval of 
insufficient glandular material and inherent sampling mistakes 
which would force a second biopsy, which would in turn 
increment patient’s morbidity. 
With the limitations intrinsic to the potential biases in the studies 
included in this meta-analysis, we conclude that minimally 
invasive lip biopsy technique for SS diagnosis induces less 
permanent neurological complications than conventional 
approaches with large linear incisions in the lower lip. Moreover, 
and due to the absence of relevant scientific evidences supporting 
the selection of a particular technique for salivary gland biopsy in 
SS diagnosis, it is recommended to undertake clinical trials to 
assess the existing approaches for lip MSG (minimally invasive vs. 
large linear incisions), together with sublingual and parotid 
biopsy, and ensuring adequate follow-up periods. 
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Key messages 
1. Minor salivary gland biopsy in the lip has proved useful for 
Sjögren’s syndrome diagnosis.  
2. Minimally invasive biopsy techniques induce less permanent 
neurological adverse events than conventional incisional 
approaches. 
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Fig 1. Flow chart of the study. 
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6. Lip biopsy for the diagnosis of Sjögren’s 
Syndrome: Beware of the punch ! 
Abstract 
A pilot study aimed at examining the presence of nerve fibres in 
minor salivary glands tissue samples obtained by two procedures 
(punch vs. linear incisional technique). The study was undertaken 
on a convenience sample of five cryopreserved corpses (mean age 
74±3.5; 3 males and 2 females), and biopsies performed on the 
buccal side of the lower lip, between the mid-line and the corner 
of the mouth. Each corpse had one side of its lower lip biopsied by 
punch and the contra-lateral side using a linear incision. All punch 
samples (100%) displayed severed nerve fibres whereas no nerve 
fibres (0%) could be identified in the samples obtained by means 
of the linear incision technique. Within the limitations the study, 
our results strongly discourage punch techniques for minor 
salivary gland lip biopsies and provide information on the 
superiority of linear incisional biopsies in terms of neural damage. 
These results may also recommend undertaking clinical trials on 
patients suspicious for SS comparing the morbidity associated to 
linear incisional technique vs. minimally invasive biopsies. 
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Introduction 
Minor salivary gland biopsy (MSGB) has been used for the 
diagnosis of systemic disorders, like amyloidosis, sarcoidosis, 
Sjögren’s syndrome (SS) and for the confirmation of neonatal 
hemochromatosis. 
The presence of focal lymphocytic sialadenitis with a focus score 
>1 per 4 mm2 of glandular tissue is an objective criterion to 
consider when diagnosing Sjögren’s syndrome. MSGB has proved 
validity and diagnostic confidence with a high specificity and 
positive predictive value, and an average sensitivity of 79% [1]. 
These features make MSGB particularly useful for patients with 
inconclusive clinical findings, incipient forms of the syndrome, SS 
with negative anti Ro/la serology and extra-glandular 
involvement. 
A wide range of surgical approaches have been described for 
harvesting at least five accessory glands from the lower lip using 
different instruments (scalpel, punch, or cup forceps), and for 
producing different incisions (circular, linear or elliptical) with a 
variety of sizes (from 2 mm to 3 cm) [1-5] and orientations 
(parallel to the lip, oblique, or even vertical). The use of a forceps 
with a fenestrated active end (chalazion forceps) to stabilize the 
lip has also been suggested. 
The selection of the best surgical approach in terms of related 
morbidity is hampered by the absence of comparative studies and 
the proliferation of descriptive papers that do not state negative 
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outcomes associated to the technique performed [4]. Moreover, 
those reports describing percentages of surgical complications 
have a limited validity due to the lack of standardization when 
defining and categorizing the complications according to their 
severity [4,5]. Anyhow, persistent lip numbness is the most 
frequently published surgical complication [4], occurring in up to 
6% of MSGBs performed in the lower lip. 
Despite the existing investigations discouraging the removal of 
labial mucosa with attached glands when performing MSGB 
because of the potential for neurological damage, punch use has 
been widely recommended because of safety and handling 
simplicity reasons, as this procedure is not technically demanding 
and can be undertaken at an outpatient setting [2,3]. However, and 
to the best of our knowledge, there are no quality comparative 
studies assessing neurological damages induced by different 
techniques for MSGB. Thus, the aim of this pilot study was to 
examine the presence of nerve fibres in minor salivary gland 
tissue samples obtained by means of two different procedures 
(punch technique vs. linear incisional technique). 
Methods and materials 
On the basis of the feasibility of the investigation and to minimize 
potential ethical conflicts, an observational, descriptive pilot study 
designed to replicate the techniques for minor salivary gland 
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biopsy for SS diagnosis [2-4] was undertaken on a convenience 
sample of five not formolized, frozen corpses (mean age 74±3.5; 3 
males and 2 females). All subjects had bequeathed their bodies to 
the Department of Morphological Sciences for medical-scientific 
research and training purposes and all procedures were 
undertaken according to our University Ethics Committee 
(14/2007) recommendations.  
Biopsies were performed in the inner side of the lower lip, 
between the mid-line and the corner of the mouth. Each corpse 
had one side of its lower lip biopsied by punch and the contra-
lateral side using a linear incision. The biopsy site was randomly 
allocated to each technique using a computer-generated list of 
random numbers. 
The punch biopsy technique (MSGPB) was undertaken following 
previously established protocols [2,3] by everting the lip, 
perpendicularly positioning a 4 mm diameter punch (Stiefel 
laboratories, Madrid, Spain) and performing simultaneous 
rotational movements under gentle pressure to reach 8 mm deep 
into the lip. The cylinder of tissue was removed from its base using 
a scalpel with a No. 15 blade and placed onto a filter paper to 
avoid curling or twisted artefacts.  
For the incisional biopsy, the lip was stabilized with a forceps 
(OEPM nº 201200158) and the incision performed away from the 
mid-line using a No 15 scalpel blade. This incision was directed 
horizontally for about 1.5 cm, just penetrating the epithelium and 
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combined with a blunt dissection of the borders or the wound. 
Five minor salivary glands were harvested from each corpse [6]. 
All specimens were immediately introduced in a wide-mouthed 
container, coded, and fixed in a generous amount of 10% formalin 
buffered saline for 24 hours. 
A single pathologist longitudinally cut all specimens with a new 
disposable scalpel for every section to obtain 3 slices 200 μm 
apart from each specimen and orientated them before paraffin 
embedding. Samples were prepared in 4 μm sections, stained with 
hematoxylin and eosin and processed by the same technician. All 
specimens were examined using an Optiphot-2 microscope 
(Nikon, Tokyo, Japan) equipped with a millimetre-calibrated 
eyepiece graticule (Graticules Town Bridge, Kent, UK) in order to 
measure the length of the core tissue obtained by punch 
procedures. Pathological analysis also assessed the presence of 
severed nerve fibres within the tissue samples and the number of 
glands obtained by each technique. 
The scores obtained for each variable were recorded and the 
confidence intervals for the differences between techniques 
calculated by means of the Epidat 3.1 statistical package (Xunta de 
Galicia, Santiago de Compostela, Spain). 
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Results 
The punch technique for minor salivary gland biopsy produced 
specimens of 7.2±1.1 mm long. The procedure harvested one 
minor salivary gland per sample in three cases; another case 
showed 2 glands located at the same depth in the tissue sample 
and the last case showed no glandular tissue in the specimen. 
All MSGPB samples (100%) displayed severed nerve fibres, 
located deeper in the tissue than the minor salivary glands. Only 
one sample showed nerve fibres close to the glandular tissue, at a 
more superficial level (Fig 1). No nerve fibres (0%) could be 
identified in the samples obtained by means of the linear incision 
technique (Fig 2). The results are summarized in table 1. 
Pathological analysis revealed no handling-related artefacts 
(pseudo-cysts, crushing, fragmentation, haemorrhage or fissures), 
although fixing alterations could be recognized (more appealing at 
the lip mucosa epithelium and the minor salivary glands), 
probably due to the use of frozen cadaveric material. 
Discussion 
The selection of a particular technique for MSGB is limited by the 
absence of clinical trials and standardization of surgical 
complications, which seriously compromise the validity of the 
information available from the literature on this topic. Existing 
case series display a wide range of sample sizes (6 to 502 
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patients) with different frequencies of complications associated to 
the variety of techniques employed [1,4,5]: studies performing 
incisions shorter than 2 cm with a scalpel report complications 
ranging from none to 9.3% [4]  , whereas larger incisions (2 - 3 
cm) are described to cause complications in a range from 3.7% to 
31% [7]. Transient disorders of lip sensitivity occurred in up to 
11.7% of the procedures [4], and those studies with follow-up 
periods beyond one year report persistent lower lip hypoaesthesia 
in about 3.4% to 4% of the cases [4]. Only minimally invasive 
techniques [5,6] (excluding punch), based upon multiple 2 to 3 
mm scalpel incisions on the inner side of the lower lip combined 
with a cup forceps to retrieve the tissue samples have proved 
absence of neurological morbidity after a 1.5 years follow-up 
period [4]. 
However, minor salivary gland punch biopsy has been suggested 
as an alternative to incisional biopsy techniques precisely because 
of the absence of risk for the patient, its simplicity (can be 
performed by a single operator) and also because it is less 
expensive [2,3]. This technique consists on biopsy taking from the 
buccal side of the lower lip -which is stabilized by the patient 
him/herself- using a 4 to 5 mm punch which permits the retrieval 
of a tissue cylinder up to 8mm long [2,3]; no complications have 
been reported using this protocol in a series of 14 patients [3] and 
only 4% of transient numbness in a series of 50 cases with 
unspecified follow-up period [2]. 
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Although this approach may seem interesting, the percentages of 
undesired events reported in these investigations [2,3] should be 
considered with caution as they are unexpectedly well under 
those described for incisional techniques, where sensory nerves 
can be clearly seen and subsequently avoided, and also because 
they strongly disagree with our results obtained under controlled 
experimental conditions.  
In general, sample size calculations may not be required for pilot 
studies, as they are focused mainly on feasibility rather than on 
statistical signification. However, it has to be kept in mind that 
studies with small sample sizes may not disclose differences 
between groups. Despite our study was performed on a small 
series of cadaveric material, the massive differences in terms of 
neural damage between techniques disclosed by this study seem 
to suggest that chances for error are remote, irrespective of 
sample size issues. Moreover, post-mortem studies have been 
frequently employed when validating glandular biopsy for SS 
diagnosis [8]. Fresh, cryopreserved (frozen) corpses are the best 
model in terms of similarity of tissue quality and surgical 
handling. The age of the patients in the series (>50) may also be 
and advantage, because as persons grow older fibrosis and 
reductions of the acinar volume occurs which is a similar situation 
to that found in SS patients [8]. 
Previous reports have described collection of an average of six 
MSG using incisional techniques 1.5 y 2cm [1,4,5,7]. Additionally, 
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our study on MSGB using a 1.5 cm linear incision permitted 
retrieval of at least 5 glands, whereas punch-biopsy did not 
provide enough gland material for diagnosis of SS in any situation. 
Incisional techniques (including those minimally invasive) have 
enabled the retrieval of an average of more than 5 glands 
accompanied by only a 1.6% of undesired material, mostly fatty or 
fibromuscular in nature [5]. In contrast, sampling errors are an 
inherent handicap for punch techniques, which sometimes require 
an additional biopsy on the other side of the lip [2] and increases 
morbidity. The reduction of surgical time to a “few minutes” [2] 
does not seem to be an advantage for punch biopsy either, as 
incisional biopsies using linear incisions take from 5 minutes to 9 
[7]. Minimally invasive techniques can also be performed within a 
minimal operative time.  
Alternative procedures to MSGB for SS diagnosis, such as 
sublingual salivary gland biopsy [9] or parotid biopsy [10] caused 
no neural morbidity. These comparative studies seem to suggest 
that both procedures -sublingual and parotid biopsy- retain a 
diagnostic potential comparable to that of lip biopsy and may be 
related to lower postoperative morbidity [9-10]. 
Within the limitations of this kind of studies, our results 
discourage the use of punch techniques for biopsies of minor 
salivary glands in the lip and provide information on the 
superiority of linear incisional biopsies in terms of neural damage. 
The results of this pilot study may permit the recommendation of 
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undertaking clinical trials on patients suspicious for SS comparing 
the morbidity associated to MSGB (linear incisional technique vs. 
minimally invasive) and major salivary gland biopsy . 
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Figure legends. 
Figure 1: H&E 4x. Deep portion of a lower lip sample obtained by 
punch biopsy: sectioned nerve fibres can be seen close to a minor 
salivary gland. 
 
Figure 2. H&E 4x. Minor salivary gland obtained by linear 
incisional technique. 
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Table legend. 
 
Case Age Gender 
Specimen 
 length 
(mm) 
No. of accessory 
glands 
Presence of 
nerve tissue 
Punch 
Linear 
incision 
 
Punch 
Linear 
incision 
1 76 F 5.5 - 5 + - 
2 72 M 7.0 1 5 + - 
3 79 M 7.0 1 5 + - 
4 70 F 8.5 1 5 + - 
5 73 M 8.2 2 5 + - 
Table 1. Number of glands and presence of nerve tissue in the 
specimens. 
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7. Minor salivary gland biopsy in Sjögren's syndrome: 
a review and introduction of a new tool to ease the 
procedure. 
Summary 
Objectives: To review the existing techniques for minor salivary 
gland biopsy (MSGB) in the lip and to suggest a new approach to 
ease the procedure and reduce post-operative complications. 
Study design: A comprehensive literature review and a descriptive 
study of a new surgical technique  
Results: Diverse incisions have been suggested for MSGB with 
different designs (ellipse, circular, linear), different directions 
(parallel, oblique, vertical) and a wide range of lengths (from 1 
mm up to 3 cm), but no comparative studies supporting the 
advantages of a particular type of incision over the others could be 
retrieved. A variety of features of the existing techniques for 
MSGB are linked to undesired events and surgical complications 
which could be minimized by modifying certain aspects of these 
procedures. The technique described, together with the use of the 
S forceps, represents a significant improvement over the already 
described chalazion forceps because it allows for a better access 
and positioning of the lower lip, improves the ergonomic 
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conditions of the assistant, and facilitates the identification of lip 
areas with more superficial gland lobules. 
Conclusion: The suggested approach for lip MSGB includes a 
specifically designed instrument whose performance during lip 
biopsy may contribute to minimize post-operative complications. 
Keywords 
Sjögren's syndrome; diagnosis; minor salivary gland biopsy; 
surgical technique; lower lip.  
Introduction 
The Sjögren’s syndrome (SS) is an autoimmune exocrine disorder 
with signs and symptoms of dry mouth and keratoconjunctivitis 
sicca, which may sometimes display a wide range of systemic, 
non-glandular alterations (1,2). The prevalence of this syndrome 
has been estimated to range between 0.5% and 1% (3), with a 
female:male ratio of about 9:1 (1-3). 
Histopathology in minor salivary gland (presence of focal 
lymphocytic sialadenitis with a focus score ≥1) is one out of the 
six diagnostic criteria set in the revised international classification 
for Sjögren’s Syndrome (2) for diagnosis of SS. It has recently 
become more important because of the consensus in considering 
only objective criteria to define a SS case, which has to meet at 
least 2 of the following 3 findings: 1. Positivity serum anti-SSA 
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and/or SSB; 2. Ocular staining score >3; and 3. Presence of focal 
lymphocytic sialadenitis with a focus score >1 per 4 mm2 of 
glandular tissue (2). 
A systematic review on minor salivary gland biopsy (MSGB) has 
proved diagnostic value for SS with high specificity (X±SD= 
88.1±11.7) and sensitivity (X±SD= 78.8±11.2), as well as 
diagnostic confidence in terms of positive (X±SD= 87.6±9.5) and 
negative (X±SD= 79.0±16.9) predictive values (3). These results 
make this technique particularly useful for patients suspicious for 
SS with inconclusive clinical findings (4). MSGB may also 
contribute to diagnosis of amyloidosis, sarcoidosis, and 
confirmation of neonatal hemochromatosis (3,5,6). 
Despite the different surgical approaches suggested for MSGB (use 
of chalazion forceps for tissue stabilization, usage of scalpel vs. 
punch, different incision sizes, and need or not for suturing), both 
immediate and mediate complications are continuously described 
in the literature, being the most relevant a long-lasting lower lip 
numbness occurring in up to 6% of MSGB procedures (7). These 
events support the need for a review of the technique to reduce 
morbidity. In this sense, we suggest the use of a specifically 
designed forceps for lip biopsy in SS patients that improves tissue 
stabilization, eases the procedure, and reduces complications. 
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Materials and methods 
 The materials required for this technique include a syringe for 
intraoral local anaesthesia, scalpel with a No. 15 blade, non-
toothed Adson forceps, 4/0 braided silk suture, and the “S” 
forceps for biopsy (OEPM nº 201200158) (Fig.1). This is a 18.5 cm 
long forceps with a fenestrated active end (5 cm2). Both the 
fenestrated area (longitudinal to the axis of the forceps) and its 
wide size are conceived to provide an ample surgical field. The 
non-fenestrated blade of the forceps is slightly convex in shape to 
facilitate herniation of minor salivary gland lobules. There is a 
screw in the shank for adjustment of the space between the 
blades, thus permitting a variable and controlled pressure over 
the soft tissues during the surgical procedure. The handles of the 
forceps are at an angle with the blades to help traction and 
visibility of the surgical field. This angle also permits the forceps 
to work as a surgical separator improving accessibility by means 
of a traction-separation movement. 
Technique 
The biopsy site should be selected from the inner side of the lower 
lip, rich in minor salivary glands, avoiding the midline area due to 
its lesser content of glandular component (Fig.2). 
Local anesthesia is performed by perilesional infiltration or 
blockage of the mental nerve. Once anesthesia is achieved, the 
whole lower lip is stabilized using the S forceps, and the biopsy 
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site selected taking advantage of the forceps design which forces 
the gland lobules to protrude through the fenestrated blade. 
A horizontal linear incision of about 1 cm to 1.5 cm is performed 
away from the midline, combined with a blunt dissection of the 
borders of the wound. At this stage, the lobules are herniated 
towards the surface of the wound pushed by the non-fenestrared, 
convex, blade of the forceps (Fig. 3). Five to seven lobules can now 
be gently removed using the Adson tweezers and introduced into 
an abundant fixing solution (at least ten fold the volume of the 
tissue sampled). The wound is then sutured with interrupted 
single sutures. Use of magnification is recommended when 
performing the technique in order to identify superficial nerves 
and vessels and to diminish surgical morbidity. 
Observations about the technique 
MSGB of the lip is a key diagnostic tool for the diagnosis of 
systemic disorders and particularly of SS. 
The technique described above, together with the use of the S 
forceps, represents a significant improvement over the already 
described chalazion forceps because it allows for a better access 
and positioning of the lower lip, improves the ergonomic 
conditions of the assistant, and facilitates the identification of lip 
areas with more superficial gland lobules. It also permits a better 
bleeding control during surgery, an enhanced visualization of 
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vessel and nerve endings, reduces the surgical time, and provides 
non-artefacted lobules for pathological analysis (Fig. 4). 
Discussion 
Techniques and complications in MSGB 
Despite there is a wide agreement on avoiding the glandular-free 
zone in the centre of the lower lip, it seems to exist a remarkable 
lack of standardisation of the MSGB technique when aimed at 
obtaining at least five glandular lobules for the diagnosis of SS (8).  
Different incisions have been suggested with different designs 
(ellipse, circular, linear), different directions (parallel, oblique, 
vertical) and a wide range of lengths (from 1 mm up to 3 cm), but 
no comparative studies supporting the advantages of a particular 
type of incision over the others could be retrieved (9-19). 
Most frequent immediate surgical complications include intra- 
and post-operative bleeding (9,11). Pain, inflammation, wound 
infection, suture dehiscence, and cheloid scars are described as 
mediate complications of glandular biopsy (7,9-15), but the so-
called “disorders of lip sensitivity” are the most frequently 
reported complication (18, 19), occurring in up to 11% of cases in 
large series (12). This finding has discouraged the use of a punch 
for MSGB because it removes lip mucosa together with the 
attached gland, and favoured techniques that permit identification 
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and avoidance of sensory nerve endings (16). These complications 
may well justify that only patients in a community setting with 
negative results for anti-RO/la antibodies would be referred for 
MSGB (20). 
Lip stabilization devices 
In this sense, some authors have suggested the use of chalazion 
forceps, employed by ophtalmologists during chalazion exeresis, 
to ease biopsy of minor salivary gland from mobile lip tissue, as it 
permits tissue stabilization and to work under ischemic 
conditions (6,7). However, this instrument was originally 
designed for ophthalmology and has a number of shortcomings 
for oral use: the handles of the chalazion forceps are small-sized 
to allow finger control and are placed perpendicular to the main 
axis of the blades; this forces the assistant’s hand to work on an 
uncomfortable position, too near to the surgical field. The size of 
the fenestration also limits the incision design, particularly when 
undertaking minimally invasive techniques with multiple 2 mm 
incisions along the inner face of the lower lip (13,18,19). An 
improved chalazion forceps was introduced by López-Jornet & 
Bermejo-Fenoll (21): this forceps was larger than the original (20 
cm.) and its active end provided a constant pressure of 1Kg/cm2 
on the tissues exerted by means of two flat plates (one of them 
with a round opening, sized 1.7 cm diameter). This design eases 
lip stabilization by the assistant, but it is impossible to graduate 
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the pressure on the lip tissue and the fenestrated blade provides a 
reduced surgical field. 
On the other hand, the forceps we suggest for MSGB, besides 
permitting a controlled pressure adapted to the surgical time and 
to the features of the lip of the patient (macrochelia, etc.), allows a 
more ergonomic hand grasp in such a way that keeps the 
assistant’s hand away from the working area without disturbing 
the surgeon. Moreover, the width of the fenestrated blade in this 
forceps conditions neither the design nor the size of the incisions 
as well as permits minimally invasive techniques, where a wide 
surgical field is required to harvest glandular tissue all over th 
inner side of the lower lip  (18).  
Conclusion 
This forceps stabilizes lip tissues, avoids excessive intra-operative 
bleeding, permits better visibility of the surgical field, allows 
improved selection of tissue samples for pathological analysis and 
has a potential to minimize the morbidity related to iatrogenic 
nerve lesions. 
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Figure legends: 
Fig 1. “S” forceps. 
 
Fig 2. “S” forceps in use 
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Fig 3. Excision of a minor salivary gland 
 
 
Fig 4. Minor salivary gland (H&E x10) 
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8. Discussion 
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8. Discussion 
Essentially, all studies considered in our meta-analysis are 
descriptive case-series with a low risk for selection bias, use 
heterogeneous criteria for defining complications, and employ 
different follow-up periods. Data collection procedures are also 
insufficiently described, and only one study reported the use of a 
structured questionnaire for this purpose (Caporali et al, 2008); 
another three studies displayed their results as mediate and 
immediate complications (Friedman et al, 2002; Caporali et al, 
2008; Lida-Santiago et al, 2012). 
Unfortunately, most studies on this topic show potential 
confounding variables related to the surgical setting, the clinical 
features of the patient, and even to toxic habits such as tobacco 
consumption, etc. which had not been adequately controlled; and 
any of these factors may compromise the validity of the 
investigations. Anyhow, our meta-analysis revealed a higher 
proportion of postoperative complications in those reports with 
higher methodological quality.  
Actually, all approaches for minor salivary gland biopsy may be 
grouped under two headings: techniques using small incisions 
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(minimally invasive) vs. approaches using wide incisions aimed at 
harvesting at least five glandular lobules. Another key point that 
remains unclear is about which gland is the most suitable one for 
obtaining the diagnostic sample: some reports have described an 
absence of neurological morbidity after sublingual (Pennec et al, 
1990; Berkin et al, 2006) or parotid (Marx et al, 1998; Pijpe et al, 
2007) gland biopsy for SS diagnostic purposes. 
Bearing in mind the potential limitations of the studies included in 
this meta-analysis, it appears that minimally invasive approaches 
using small (even multiple) incisions cause less morbidity in 
terms neurological damage than techniques using wide incisions. 
Nonetheless, the scientific community should undertake 
methodologically sound clinical trials for testing this hypothesis 
without any risk for biases. 
It is also worth mentioning the paper by Gevara-Gutiérrez et al 
(2011) supporting the use of a punch for minor salivary gland 
biopsies in the lower lip. This recommendation is based upon 
their results obtained from a large sample of patients suspicious 
for SS, where only minor transient neurological complications in a 
small number of patients were found. The lack of biological 
plausibility of the results reported by this group made us assess 
this approach on an experimental model. 
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Experienced clinicians have described the inconvenience of 
removing lip mucosa together with the glandular material due to 
the higher risk for neurological damage during the surgical 
procedure because of the poor identification of anatomical 
structures. This circumstance always occurs when a circular 
scalpel (punch) is employed. Despite this fact, some research 
groups still consider this approach a convenient, minimally 
invasive, simple, and cheap procedure for lip biopsy (Bertram et 
al, 1970; Guevara-Gutierrez et al, 2001). These latter reasons, 
along with the absence of complications (Bertram et al, 1970) and 
the possibility for a single operator to undertake the procedure, 
the use of a 5mm–diameter and 8 mm-length punch has been 
proposed as an alternative to conventional biopsy for SS 
diagnosis, although no further investigations for endorsing or 
discarding this recommendation has been undertaken. 
Because of ethical issues, we have carried out a pilot study on an 
experimental model (cryopreserved corpses) aimed at assessing 
both the potential damage to lip nerve tissue and the amount of 
glandular tissue obtained under this biopsy protocol with punch. 
This model has been widely employed for validating this kind of 
techniques, as the particularities of this particular model in terms 
of surgical handling and condition of the glandular content closely 
resemble those of SS patients (Chisholm  et al, 1968; Chisholm et 
al, 1970).  
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This pilot study, performed on a reduced sample, has disclosed 
sectioning of sensitive nervous fibres in all cases; and this finding 
makes us discourage the use of circular scalpel for lip biopsy.  
A number of devices aimed at easing this surgical technique, 
particularly for stabilizing the lip, have been previously described 
(Seoane et al, 2000; Lopez-Jornet et al, 2005). The first reports on 
this issue used ophthalmologic devices (Seoane et al, 2000) for 
this sake, although limitations like the size and the orientation of 
the fenestration of the forceps and the poor access to posterior 
areas in the mouth, mainly due to the presence of the pressure-
regulating screw too close to the active end of the forceps. This 
limitation was solved in successive prototypes (López-Jornet et al, 
2005), although some drawbacks still remained, such as the 
impossibility for maintaining a controlled pressure, and the 
existence of a small, circular, fenestrated area. These features 
made these devices unsuitable for both approaches requiring 
wide incisions, and also for minimally invasive techniques 
involving multiple incisions in both sides of the lip. 
In order to solve these shortcomings, we have developed a new 
instrument with improved ergonomics that permits a better 
access to the whole of the lower lip while allowing a controlled 
pressure capable of producing surgical ischemia for an adequate 
visibility of the nerve fibres. We have also described the technique 
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for lip biopsy in this clinical context (SS), although clinical trials 
are needed for assessing the suggested approach. 
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9. Conclussions 
1. Glandular biopsy is a key criterion for the diagnosis of Sjögren's 
syndrome because of its high diagnostic validity. Despite the 
absence of comparative studies, minimally invasive techniques 
using small, multiple incisions seem to induce fewer permanent 
neurological complications than conventional approaches using 
longitudinal incisions in the lower lip. However, and to optimize 
the process of making surgical decisions, clinical trials comparing 
the lip with alternative sites for salivary gland biopsy -such 
sublingual or parotid glands- are needed. 
2. The use of circular scalpels are strongly discouraged for 
glandular biopsy in the lip, due to the impossibility of harvesting 
glandular tissue enough for diagnostic purposes, the lack of 
specificity of the sample obtained, and also to the high probability 
for neurological damage during the procedure. However, lip 
stabilization forceps may become a useful ancillary instrument for 
lip biopsy, whose contribution should be analyzed in future 
clinical trials. 
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10. Resumen 
Los criterios de síndrome de Sjögren consideran la biopsia de 
glándula salival menor (≥1 foco por 4mm2), junto con la tinción 
ocular del Rosa de Bengala (>3) y la positividad de la serología 
(SSa/SSB) entre los requerimientos para establecer un 
diagnóstico.  
La biopsia glandular ha proporcionado en estudios previos un alto 
valor predictivo, así como una considerable sensibilidad (78.8%) 
y especificidad diagnóstica (88.1%). Además esta seguridad 
diagnóstica puede ser incrementada, utilizando índices 
acumulados, con el estudio a diferentes niveles de la muestra. 
10.1. Reacciones adversas neurológicas descritas tras 
biopsia labial en pacientes sospechosos de 
Síndrome de Sjögren: Una revisión sistemática y 
meta-análisis. 
La biopsia labial de glándulas salivares menores como método 
diagnóstico no está exento de morbilidad (dolor, inflamación, 
hematomas, sangrado, infección…etc), incluso de complicaciones 
neurológicas potencialmente severas y permanentes (anestesia, 
hipoestesia y/o disestesia labial). En cualquier caso, existen un 
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gran número de diferentes técnicas de biopsia labial glandular con 
diseños elípticos, circulares o lineales, de diferentes longitudes  
(2mm a 30 mm) y con diferentes direcciones (paralelas, oblicuas o  
transversales), respecto a la dirección de las fibras del orbicular 
del labio. A pesar de esta circunstancia no existen estudios 
comparativos o ensayos clínicos que permitan elegir al clínico el 
procedimiento con menor morbilidad. 
Estas circunstancias parecen justificar la necesidad de un meta-
análisis encaminado a responder qué técnicas quirúrgicas 
(mínimamente invasivas vs convencionales –incisiones lineales de 
≥5mm-) generan menos efectos adversos en términos de 
morbilidad neurológica. 
En Junio de 2013, se llevó a cabo una revisión sistemática con 
metanálisis que incluyó las bases MEDLINE (1966-2013), EMBASE 
(1980-2013) y Proceedings Citation Index Science (CPCI-S), así 
como mediante búsqueda manual en revistas especializadas para 
artículos publicados en cualquier idioma. En la estrategia de 
búsqueda se utilizaron los términos [(salivary gland biopsy OR 
labial biopsy OR lip biopsy) AND (Sjögren)]. Está búsqueda fue 
realizada independientemente por cada autor. 
Para efectuar este metanálisis se siguió el consenso PRISMA para 
metodología de revisiones sistemáticas y metaanálisis, 
considerando como criterios de inclusión:  
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I. Los estudios que incluyan datos originales sobre 
biopsia glandular labial con intenciones diagnósticas de 
síndrome de Sjögren.  
II.  Incluir el tamaño muestral y la exposición de interés 
(descripción detallada de la técnica quirúrgica).   
III. La presencia o ausencia de complicaciones neurológicas 
y el número de pacientes afectados.  
Para la asignación de calidad se utilizó una escala binaria de 5 
puntos para estudios observacionales  (STROBE) y tanto la 
aplicación de los criterios de elegibilidad como la asignación de la 
calidad a los estudios fue llevada a cabo por dos observadores de 
forma independiente. Todos los análisis se hicieron mediante el 
software HEPIMA, versión 2.1.3. 
Mediante la anteriormente citada búsqueda sistemática se 
identificaron 342 estudios potencialmente elegibles y finalmente 
se consideraron 3 estudios sobre las técnicas mínimamente 
invasivas (TMI) y 13 estudios con información relevante sobre 
técnicas de incisión lineal convencional.  Las medidas de los 
efectos presentaron  una baja heterogeneidad, excepto para los 
estudios con TMI, para los que se seleccionó la medida de efectos 
aleatorios. Estos resultados muestran una mayor morbilidad 
neurológica asociada a incisiones lineales de más de 5 mm, frente 
a incisiones labiales mínimamente invasivas. Sin embargo, la 
interpretación de los mismos habrá de ser cautelosa debido a 
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potenciales sesgos metodológicos, especialmente ligados al sesgo 
de selección, falta de representatividad de la muestra, variabilidad 
de las habilidades quirúrgicas, débil descripción de las muestras, 
el empleo de criterios heterogéneos  en la definición de las 
complicaciones quirúrgicas…etc. 
Por otra parte, la biopsia labial ha demostrado seguridad 
diagnóstica en formas de SS poco definidas, con serología negativa 
(SSa/SSB) y específicamente formas extraglandulares del 
síndrome. Para ello, se ha utilizado  diferente armamentario 
quirúrgico, como el bisturí frío, el bisturí circular, las pinzas en 
sacabocados…etc. 
10.2. Biopsia labial en el diagnóstico de síndrome de 
Sjögren: Cuidado con el bisturí circular 
A pesar de que mayoritariamente los clínicos evitan la toma de 
tejidos labiales en bloque (mucosa y submucosa con tejido 
glandular), algunos autores han propuesto  el empleo de bisturí 
circular (punch), en base a criterios ergonómicos, y  a que parecen 
generar escasa morbilidad intra y postquirúrgica. Debido a que 
estos resultados parecen poco plausibles, decidimos reproducir 
los protocolos de biopsia glandular labial (BGL), utilizando un 
punch de 4 milímetros de diámetro , a una profundidad de 8 
milímetros, sobre un modelo experimental.  
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Con esta finalidad se llevó a cabo un estudio piloto, con un diseño 
a boca partida, utilizando 5 cadáveres crio-preservados. Las 
intervenciones (incisión labial horizontal de 10 milímetros  frente 
a punch) fueron asignadas de forma aleatoria, a cada lado del 
labio. Posteriormente Se efectuó un estudio histopatológico 
multinivel de las muestras mediante hematoxilina-eosina.   
En todos los casos se registró, la edad y sexo  del cadáver, así 
como, la longitud del cilindro obtenido mediante el bisturí 
circular, la presencia y número de lobulillos glandulares en el 
espécimen y la presencia de fibras nerviosas seccionadas en la 
muestra obtenida. En todas las biopsias con punch pudo 
evidenciarse  la presencia de fibras seccionadas, en tanto no se 
pudo demostrar este hallazgo en ninguna de las muestras 
obtenidas con bisturí frío.   
Estos hallazgos nos permiten sugerir la inconveniencia de utilizar 
una técnica ciega, en la que no se efectúa una  disección 
quirúrgica, y  en la que tan solo se obtienen un máximo de 1 ó 2 
lobulillos glandulares. A pesar de que estos hallazgos dimanan de 
un estudio piloto, con un escaso tamaño muestral, la propia 
esencia de este tipo de estudios esta focalizada más en la 
factibilidad y en generar hipótesis para ensayos clínicos, que en 
buscar significación en el estudio. En base a los resultados 
obtenidos, se percibe la necesidad de diseñar ensayos clínicos que 
enfrenten  técnicas mínimamente invasivas de BGL a biopsias 
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labiales incisionales lineales y a técnicas de biopsia sobre 
glándulas mayores (parótida y sublingual). 
10.3. Biopsia de glándula salival menor en el diagnóstico 
de síndrome de Sjögren: Revisión y propuesta de 
una nueva herramienta para facilitar el 
procedimiento 
Con independencia del tipo de bisturí empleado, también se han 
utilizado pinzas fenestradas (pinzas de chalazion) con la finalidad 
de  estabilizar el labio y  conseguir isquemia del campo operatorio. 
Además, un gran número de publicaciones continúan informando 
de la alta frecuencia de complicaciones inmediatas y 
postoperatorias, de diversa severidad, asociadas a la BGL. A pesar 
de ello,  se han llevado a cabo muy pocos intentos de mejorar los 
dispositivos y la técnica quirúrgica. Específicamente, las pinzas de 
chalazion (Desmarres)  presentan limitaciones a su empleo en 
biopsias labiales, básicamente debido a la forma y al área de la 
fenestración y a la falta de accesibilidad a partes 
posteriores/profundas  de los tejidos orales.  
Posteriormente y  con la misma finalidad se han diseñado las 
pinzas B, con una longitud de 20 centímetros, una fenestración de 
1,7 centímetros de diámetro y  una presión estable sobre los 
tejidos de 1 Kg/cm2. Este diseño solucionó parcialmente los 
déficits atribuidos a la pinza de chalazion. Sin embargo, la 
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fenestración de este dispositivo no permite llevar a cabo 
incisiones lineales amplias, ni TMI con incisiones múltiples. Otro 
inconveniente reside en la incapacidad de controlar la 
forcipresión e individualizarla de acuerdo a las características del 
paciente.  
Con el objetivo de evitar los inconvenientes anteriormente citados 
y de facilitar la técnica de biopsia labial, se planteó diseñar unas 
pinzas de estabilización labial y describir una técnica quirúrgica 
para la BLG en pacientes con sospecha de síndrome de Sjögren. Se 
llevaron a cabo diversos prototipos que permitiesen  incisiones 
lineales amplias, incluso mayores a 3 centímetros, el acceso a 
zonas profundas del labio, que pudiesen estabilizar el labio 
completo en caso de técnicas de incisiones múltiples bilaterales y 
que permitiese así mismo, individualizar la presión de acuerdo a 
las características del paciente.  
Fruto de ello ha sido la elaboración de las pinzas S,  con un mango 
ergonómico y una longitud total de 18,5 centímetros y un área 
fenestrada de 5 cm2. La parte activa  fenestrada presenta una 
dirección axial respecto al mango y facilita el acceso del tejido a 
biopsiar.  Además se realizó una descripción de la técnica 
quirúrgica de BLG paso a paso. 
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Neurological adverse events related to lip biopsy in
patients suspicious for Sjo¨gren’s syndrome: a
systematic review and prevalence meta-analysis
Pablo Varela Centelles1, Marin˜a Sa´nchez-Sa´nchez1, Julia´n Costa-Bouzas2,
Juan Manuel Seoane-Romero1, Juan Seoane1 and Bahi Takkouche3
Abstract
Objective. The aim of this study was to compare the prevalence of neurological complications related to
lip biopsy for SS diagnosis using conventional vs minimally invasive techniques.
Methods. We performed a systematic review and prevalence meta-analysis using the search strategy
[(salivary gland biopsy OR labial biopsy OR lip biopsy) AND (Sjo¨gren)] in the MEDLINE, EMBASE and Web
of Science Conference Proceedings Citation Index databases. Studies were selected if they included
original data for minor salivary gland biopsy, sample size, exposure of interest (technique description),
number of complications and number of affected patients. The prevalence of total and permanent neuro-
logical adverse effects was calculated. Both fixed-effects and random-effects pooled estimates were
assessed. Heterogeneity was calculated using an adaptation of the DerSimonian and Laird Q test.
Results. Sixteen articles were selected for the study. In the minimally invasive group (n=3), the pooled
prevalence of total adverse events is almost four times higher than that in the linear incision group (n=12)
(4.73% vs 1.20%). In contrast, the pooled prevalence of the permanent or potentially permanent neuro-
logical adverse events is 8.5 times lower in the minimally invasive technique group than in the studies
using linear incisions (0.17% vs 1.45%).
Conclusion. With the limitations intrinsic to the potential biases in the studies included in this meta-
analysis, we conclude that the minimally invasive lip biopsy technique for SS diagnosis induces fewer
permanent neurological complications than conventional approaches with large linear incisions in the
lower lip.
Key words: Sjo¨gren’s syndrome, lip biopsy, minor salivary gland, diagnosis, adverse events, complications,
neural damage.
Introduction
Since Chisholm and Mason [1] described minor salivary
gland biopsy (MSGB) as a valuable investigative proced-
ure in SS and established standardized criteria to assess
inflammation, a number of surgical techniques have been
suggested to harvest MSG for SS diagnosis. Focal siala-
denitis (with a focus score 51) in MSG is one of the six
requirements established for the diagnosis of SS [2]. This
criterion has become more important as a recent consen-
sus limits the definition of SS to objective criteria only and
therefore two of the three criteria would then be required:
positive serum anti-SSa and/or SSB, ocular staining score
>3 or the presence of focal sialadenitis with a focus score
>1 per 4mm2 of glandular tissue [3].
The value of MSGB for the diagnosis of SS is supported
by high sensitivity [mean 78.8 (S.D. 11.2)] and specificity
[88.1 (11.7)] values [2], reinforced by good diagnostic con-
fidence [positive predictive value 87.6 (9.5); negative pre-
dictive value 79.0 (16.9)]. This diagnostic value can be
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augmented by evaluating the cumulative focus score
using a multilevel approach, assessing different section
levels of the sampled glandular tissue cut at least at
200mm apart [4]. Thus MSGB can be particularly useful
for suspected SS patients with inconclusive clinical find-
ings and negative anti-Ro/la serology [5, 6].
A number of mediate and immediate surgical complica-
tions (pain, bruising, bleeding, wound infection) have been
described for MSGB, but lip numbness has been found to
be the only persistent complication and it is reported to
occur in up to 6% of all MSGBs [79]. Several techniques
for lip MSGB have been proposed with a variety of inci-
sions differing in shape (elliptical, circular, linear), orienta-
tion (vertical, oblique, parallel) and length (1mm3 cm),
but no comparative studies on the advantages of a par-
ticular type in terms of postoperative morbidity could be
retrieved [7, 919].
The high diagnostic performance of MSGB demands an
adequate surgical technique to ensure correct and suffi-
cient sampling of glandular tissue with low related mor-
bidity. Technique selection is hindered by the absence of
comparative studies and the limited validity of the sole
comprehensive review on the topic identified in the litera-
ture, due to the poor definition and vague categorization
of the surgical complications [11]. These circumstances
seem to justify the need for a systematic review and
meta-analysis aimed at assessing the prevalence of
neurological complications related to lip biopsy. The aim
of this investigation was to compare the pooled preva-
lence of neurological adverse events induced by lip
biopsy for the diagnosis of SS (minimally invasive tech-
nique vs linear incisions 55mm).
Methods
Methods of analysis and inclusion criteria were defined in
a protocol to ensure homogeneous criteria among all co-
authors during the investigation. This protocol was initially
conceived to record all post-biopsy adverse events
described in the literature, but it was restricted later on
during the study to permanent neurological adverse
events.
A systematic search was undertaken in June 2013 of
the MEDLINE, EMBASE and Web of Science Conference
Proceedings Citation IndexScience (CPCI-S) databases.
The search strategy was [(salivary gland biopsy OR labial
biopsy OR lip biopsy) AND (Sjo¨gren)], both in medical sub-
ject headings (MeSH) and in free text words. This search
strategy was independently reviewed and discussed by all
authors.
This search was supplemented with an additional
manual search [20] performed on our institution‘s library
catalogue, considering both books and relevant journals,
including Annals of the Rheumatic Diseases, Arthritis &
Rheumatism, Arthritis Research & Therapy, Osteoarthritis
and Cartilage, Rheumatology and the reference lists of the
articles retrieved from the aforementioned databases
(Fig. 1). All references identified for computerized data-
bases were manually retrieved. Studies were included if
they fulfilled the following criteria: (i) included original data
from an MSGB performed for the diagnosis of SS;
(ii) included the sample size and the exposure of interest
in the study, i.e. a detailed description of the techniques
for MSGB; and (iii) assessed the presence or absence of
neurological complications (lip numbness) and number of
affected patients.
Data were retrieved by two investigators in an unblinded
standardized manner using a custom-made extraction
sheet. Disagreements between investigators were
resolved by consensus. The percentage of technique-
related neurological complications was again independ-
ently recorded by the reviewers; in case this information
was not detailed in the study, lower lip numbness was
considered as persistent/permanent when lasting 56
months after the biopsy procedure.
Quality assessment
We assessed study quality using a 5-point binary scale
(0/1) that we specifically developed for this study. The
scale is based on Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) guide-
lines [21]. Throughout this assessment, when the informa-
tion on a specific item was not provided by the authors,
we graded this item as 0. The quality scoring was inde-
pendently undertaken by two researchers (J.S. and B.T.).
The first item assessed was whether post-biopsy
complications were a primary or specific objective of
the reported investigation or were considered in a pre-
specified hypothesis; in this case, a score of 1 was allo-
cated. The second item assessed was the study design
(1 point to clearly described prospective designs). The
third item assessed was the setting of the study (1 point
was given if the article adequately described both the sur-
gical scenario and data collection procedures). The fourth
item assessed the follow-up time after surgery (1 point if
follow-up dates or dates at which the outcome events
occurred were present). The last item concerned descrip-
tive data on one important confounder: the number of
glands harvested (1 point if the number of glands obtained
was detailed in the article).
Data synthesis and analysis
The concept of minimally invasive techniques included
those techniques for MSGB consisting of multiple
23mm incisions on the buccal side of the lip to collect
the glandular tissue using a forceps. Punch techniques
are not included within this group [9, 10, 13, 18].
Another group of studies was defined as those reports
harvesting glandular tissue from the lower lip by means
of a single, linear, 55 cm incision. For each study we
computed the prevalence of total neurological adverse
events and that of neurological permanent or potentially
permanent adverse events by dividing the number of
events by the sample size of the study. We then weighted
the study-specific prevalence by the inverse of their vari-
ance to compute a pooled prevalence and its 95% CI.
We calculated both fixed-effects and random-effects
pooled estimates, but used and reported the latter when
heterogeneity was present, as the random-effects model
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is generally thought to give more reliable results than the
fixed-effects model, including a more conservative (wider)
CI, when the studies being considered show a consider-
able degree of heterogeneity. In our study, this issue is
particularly relevant as, in general, the number of events is
small and in some studies the resulting prevalence is zero.
Therefore, instead of using the traditional asymptotic
method in order to obtain an estimate of the variance,
which was inadequate in our setting, we used the exact
method proposed by Newcombe and Altman [22].
To check for heterogeneity we used a version adapted
to small samples of the DerSimonian and Laird Q test, and
to quantify this heterogeneity we calculated the proportion
of the total variance due to between-study variance [R(I)]
[23]. All analyses were performed with the software
HEpiMA version 2.1.3 [24].
Results
The aforementioned systematic searches identified 342
articles whose abstracts were reviewed for contents
relevant to the topic of this systematic review; 301 of
these were subsequently excluded. A total of 41 articles
were then retrieved and reviewed and 7 of them were also
excluded because their information was not useful for this
study. The remaining 34 articles were checked according
to the inclusion/exclusion criteria of the present review.
Two articles were excluded because of double publica-
tion, i.e. the same information was published in more than
one article by Caporali et al. [9, 25] and Lo´pez-Amado
et al. [26, 27]. Thus only one reference by each research
group was considered in the study [9, 27]. Two articles
performed MSGB for indications other than the diagnosis
of SS [28, 29]. Three articles reported inadequate descrip-
tions of the surgical technique [17, 30, 31]. Nine articles
reported on the surgical technique, but not on its related
complications [18, 3239]. One article included only gen-
eric information on the surgical complication of MSGB
[40], and one article did not adequately describe the size
of the sample studied [19].
Sixteen articles were finally selected to enter the sys-
tematic review; two of them report additional information
FIG. 1 Flow chart of the study
Medline Embase Proceedings Handsearch
69 211 136 6422
342 single citations
Revision of the abstracts
301 excluded
41 papers selected
Revision of the whole text
7 excluded
34 papers selected
16 papers selected for the study
Inclusion/exclusion criteria 18 excluded
((“salivary gland biopsy” OR “labial biopsy” OR “lipbiopsy”) AND (“Sjögren”))
Search strategy
Not relevant: 301
Not relevant: 7
Double publication: 2
Biopsy not for S.S.: 2
Inadequate description: 3
No report on complications: 9
No details on complications: 1
Unclear sample size: 1
Minimally invasive
3 papers
Incisional technique
13 papers
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on the same series of cases [8, 49] (Fig. 1). Only three of
these articles describes neurological complications after
lip MSGB in the context of systematized data collection
on both immediate (<24 h) postoperative complications
(bleeding, fainting, tachycardia and bruising) and mediate
adverse events (pain, inflammation, suture dehiscence,
infection and granuloma or keloid scarring) [9, 10, 12].
Three case series with larger sample sizes [9, 10, 13] de-
scribe minimally invasive lip biopsy techniques and report
neurological complications in a range from 0 to 11.73%,
although permanent hypoaesthesias account for not more
than 0.22% [9]. In contrast, 12 descriptive studies per-
forming biopsies using 5- to 30-mm long linear incisions
using a scalpel [8] with or without a chalazion forceps
report neurological complications in a range from 0 to
5.7% that remained after 6 months.
Table 1 presents the characteristics of the studies
included in this meta-analysis. Four studies did not pro-
vide information on permanent neurological adverse
events and were excluded from this specific calculation.
Their patients were not considered for calculating the
pooled prevalence. High-quality studies yielded a pooled
prevalence that was three times as high as the pooled
prevalence of low-quality studies. Both estimates
showed large heterogeneity.
Table 2 shows the pooled prevalence for each biopsy
technique. Heterogeneity between studies was low,
except for total adverse events in the minimally invasive
technique: in this group the random effects pooled preva-
lence is thus a more germane measure than that of the
fixed-effects model. In the minimally invasive group, the
pooled prevalence of total adverse events is almost four
times higher than that in the linear incision group (4.73%
vs 1.20%). In contrast, the pooled prevalence of the per-
manent or potentially permanent neurological adverse
events is 8.5 times lower in the minimally invasive tech-
nique group than in the group of studies using linear inci-
sions (0.17% vs 1.45%). Moreover, studies performing
linear incisional biopsies report lower percentages of
complications in case series with a high proportion
(550%) of chronic saladenitis (1.01% vs 1.59%). When
studies performing linear incisional techniques were stra-
tified by quality, those studies with high scores (Q53)
report a higher percentage of permanent neurological ad-
verse events (2.50% vs 0.82%) (Table 2).
Discussion
Our study shows that minimally invasive biopsy tech-
niques are apparently safer than conventional incisional
approaches. No clinical trials focused on the aims of this
meta-analysis could be retrieved. All reports considered in
this systematic review are cases series without missing
patients for follow-up, so a selection bias is improbable.
Alternatively, there is a potential for information bias, as
only three studies describe systematized procedures for
recording information on immediate and mediate compli-
cations [9, 10, 12] and only one investigation employed
a structured questionnaire with open and closed ques-
tions [9].
There also is an evident lack of consensus on the def-
inition and classification of postoperative complications
by severity [41], which may have facilitated inaccuracies
and omissions during data collection. Very few studies
provided information on confounding factors [12, 42],
such as corticosteroid therapy, radiotherapy, tobacco
consumption, clinical setting (inpatient vs outpatient) or
chronic sialadenitis rate (Table 2), which may influence
post-biopsy complications [1, 8, 10, 12, 13, 17, 43]. In
fact, only one investigation [12] made an attempt to ad-
dress this issue during data analysis by stratifying the
results by the use of sutures, and concluded it made no
difference in terms of frequency and type of complica-
tions. This observed lack of control for confounding fac-
tors may hamper the internal validity of the reports
included in this meta-analysis, as high-quality studies
detect higher percentages of neurological complications
(Table 2).
MSGs in the lower lip are distributed into one to three
layers of discrete gland clusters, mainly in the cuspid-pre-
molar area [44]. The fact that minimally invasive tech-
niques harvest only the more superficial glands would
explain the reduced risk of damaging sensory nerves
[13] and the lower prevalence of permanent neurological
complications. However, the need for multiple, small inci-
sions and the proximity of nerve endings to the glands
may explain the presence of postoperative transient lip
hypoaesthesias. Conventional techniques require larger
incisions and dissection of the wound borders to retrieve
glands from deeper layers in the lip, where nerve fibres
and glandular tissue are in close proximity, which may well
explain the higher prevalence of permanent lip
hypoaesthesias in this group.
Both approaches permit the fulfilment of SS diagnostic
requirements, i.e. retrieval of at least five MSGs [45, 46], in
a minimal operative time [18, 47], and both share common
shortcomings, i.e. harvesting similar percentages of fatty
and fibromuscular tissues and a comparable number of
biopsies resulting in insufficient amounts of glandular
tissue [7, 10].
Two of the studies included in the meta-analysis did not
report neurological morbidity after sublingual salivary
gland biopsy [15, 48], whereas two studies found neither
sensory nor motor nerve loss related to parotid gland
biopsy for the diagnosis of SS [7, 47]. These comparative
studies seem to suggest that both procedures—sublin-
gual and parotid biopsy—have a diagnostic potential for
SS comparable to MSGB, but they may offer minor post-
operative morbidity. Alternatively, MSGB has been proved
safe, simple and suitable for extensive routine application
in outpatient (internal medicine and rheumatology) set-
tings [7, 9].
Despite the fact that techniques removing labial
mucosa together with its attached glands have been dis-
couraged because of the potential for neurological
damage [16], a research group has recommended the
use of a punch (4mm diameter) for taking biopsies from
the inner side of the lower lip. This article described rate of
transient numbness of only 4% in a series of 50 patients
4 www.rheumatology.oxfordjournals.org
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with unknown follow-up periods [17]. This approach has
the drawbacks of retrieval of insufficient glandular material
and inherent sampling mistakes, which would force a
second biopsy, which would in turn increase the patient’s
morbidity.
With the limitations intrinsic to the potential biases in the
studies included in this meta-analysis, we conclude that
the minimally invasive lip biopsy technique for the diagno-
sis of SS induces fewer permanent neurological compli-
cations than conventional approaches with large linear
incisions in the lower lip. Moreover, and due to the ab-
sence of relevant scientific evidence supporting the selec-
tion of a particular technique for salivary gland biopsy in
the diagnosis of SS, it is recommended that clinical trials
be undertaken to assess the existing approaches for lip
MSGB (minimally invasive vs large linear incisions), to-
gether with sublingual and parotid biopsies, and ensuring
adequate follow-up periods.
Rheumatology key messages
. Minor salivary gland biopsy in the lip has proved
useful for the diagnosis of SS.
. Minimally invasive biopsy techniques induce fewer
permanent neurological adverse events than con-
ventional incisional approaches for the diagnosis
of SS.
Disclosure statement: The authors have declared no
conflicts of interest.
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Abstract. A pilot study was performed to examine the presence of nerve ﬁbres in
minor salivary gland tissue samples obtained by two procedures: punch and linear
incisional techniques. The study was undertaken on a convenience sample of ﬁve
cryopreserved corpses (mean age 74  3.5 years; three males and two females).
Biopsies were performed on the buccal side of the lower lip, between the mid-line
and the corner of the mouth. Each corpse had one side of the lower lip biopsied by
punch and the contralateral side using a linear incision. All punch samples (100%)
displayed severed nerve ﬁbres, whereas no nerve ﬁbres (0%) could be identiﬁed in
the samples obtained by means of the linear incision technique. While the linear
incision approach permitted retrieval of at least ﬁve glands, punch biopsies did not
provide enough material for the diagnosis of Sjo¨gren’s syndrome. Within the
limitations of the study, our results strongly discourage the punch technique for
minor salivary gland lip biopsy and provide information on the superiority of the
linear incisional biopsy in terms of neural damage. These results may also promote
the undertaking of clinical trials on patients in whom Sjo¨gren’s syndrome is
suspected, comparing the morbidity associated with the linear incisional technique
vs. minimally invasive biopsies.
Key words: punch; biopsy; minor salivary
gland; lower lip; Sjo¨gren’s syndrome; diagnosis.
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The minor salivary gland biopsy (MSGB)
has been used for the diagnosis of systemic
disorders, such as amyloidosis, sarcoido-
sis, and Sjo¨gren’s syndrome (SS), and
for the conﬁrmation of neonatal haemo-
chromatosis.
The presence of focal lymphocytic sia-
ladenitis with a focus score >1 per 4 mm2
of glandular tissue is an objective criterion
for consideration when diagnosing
Sjo¨gren’s syndrome. MSGB has proven
validity and diagnostic conﬁdence, with a
high speciﬁcity and positive predictive
value, and an average sensitivity of
79%.1 These features make MSGB parti-
cularly useful for patients with inconclu-
sive clinical ﬁndings, incipient forms of
the syndrome, SS with negative anti-Ro/la
serology, and extra-glandular involve-
ment.
A wide range of surgical approaches
have been described for harvesting at least
ﬁve accessory glands from the lower lip
using different instruments (scalpel,
punch, or cup forceps) and for producing
different incisions (circular, linear, or
elliptical) in a variety of sizes (from
2 mm to 3 cm)1–5 and orientations (paral-
lel to the lip, oblique, or even vertical).
The use of a forceps with a fenestrated
active end (chalazion forceps) to stabilize
the lip has also been suggested.
The selection of the best surgical
approach in terms of related morbidity
is hampered by the absence of compara-
tive studies and the proliferation of
descriptive papers that do not state
negative outcomes associated with the
technique performed.4 Moreover, those
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reports describing percentages of surgical
complications have a limited validity due
to the lack of standardization when deﬁn-
ing and categorizing the complications
according to their severity.4,5 Nonetheless,
persistent lip numbness is the most fre-
quently published surgical complication,4
occurring in up to 6% of MSGBs per-
formed in the lower lip.
Despite the existing investigations dis-
couraging the removal of labial mucosa
with attached glands when performing
MSGB because of the potential for neu-
rological damage, punch use has been
widely recommended because of safety
and handling simplicity reasons, as this
procedure is not technically demanding
and can be undertaken in an outpatient
setting.2,3 However, and to the best of our
knowledge, there are no quality compara-
tive studies assessing neurological
damage induced by the different techni-
ques for MSGB. Thus, the aim of this pilot
study was to examine the presence of
nerve ﬁbres in minor salivary gland tissue
samples obtained by means of two differ-
ent procedures: punch technique and lin-
ear incisional technique.
Materials and methods
On the basis of the feasibility of the
investigation and to minimize potential
ethical conﬂicts, an observational,
descriptive pilot study designed to repli-
cate the techniques for minor salivary
gland biopsy for SS diagnosis2–4 was
undertaken on a convenience sample
of ﬁve non-formolized, frozen corpses
(mean age 74  3.5 years; three males
and two females). All subjects had
bequeathed their bodies for medical –
scientiﬁc research and training purposes
and all procedures were undertaken in
accordance with the university ethics
committee recommendations (14/2007).
Biopsies were performed at the inner
side of the lower lip, between the mid-line
and the corner of the mouth. Each corpse
had one side of the lower lip biopsied by
punch and the contralateral side using a
linear incision. The biopsy site was
randomly allocated to each technique
using a computer-generated list of random
numbers.
The punch biopsy technique was under-
taken following previously established
protocols2,3 by everting the lip, perpendi-
cularly positioning a 4-mm diameter
punch (Stiefel Laboratories, Madrid,
Spain), and performing simultaneous rota-
tional movements under gentle pressure to
reach 8 mm deep into the lip. The cylinder
of tissue was removed from its base using
a scalpel with a No. 15 blade and placed
onto a ﬁlter paper to avoid curling or
twisting artefacts.
For the incisional biopsy, the lip was
stabilized with a forceps (OEPM No.
201200158) and the incision performed
away from the mid-line using a No. 15
scalpel blade. This incision was directed
horizontally for about 1.5 cm, just pene-
trating the epithelium and combined
with a blunt dissection of the borders
of the wound. Five minor salivary glands
were harvested from each corpse.6
All specimens were immediately placed
in a wide-mouthed container, coded, and
ﬁxed in a generous amount of 10% for-
malin buffered saline for 24 h.
A single pathologist cut all specimens
longitudinally with a new disposable scal-
pel for every section to obtain three slices
200 mm apart from each specimen and
orientated them before parafﬁn embed-
ding. Samples were prepared in 4-mm
sections, stained with haematoxylin and
eosin, and processed by the same techni-
cian. All specimens were examined using
an Optiphot-2 microscope (Nikon, Tokyo,
Japan) equipped with a millimetre-cali-
brated eyepiece graticule (Graticules
Ltd, Tonbridge, Kent, UK) in order to
measure the length of the core of tissue
obtained by punch procedure. Pathologi-
cal analysis also assessed the presence of
severed nerve ﬁbres within the tissue sam-
ples and the number of glands obtained by
each technique.
The scores obtained for each variable
were recorded and the conﬁdence intervals
for the differences between techniques
calculated using Epidat 3.1 statistical
package (Xunta de Galicia, Santiago de
Compostela, Spain).
Results
The punch technique for minor salivary
gland biopsy produced specimens of
7.2  1.1 mm length. The procedure har-
vested one minor salivary gland per sam-
ple in three cases; another case showed
two glands located at the same depth in the
tissue sample and the last case showed no
glandular tissue in the specimen.
All punch biopsy samples (100%) dis-
played severed nerve ﬁbres, located dee-
per in the tissue than the minor salivary
glands. Only one sample showed nerve
ﬁbres close to the glandular tissue, at a
more superﬁcial level (Fig. 1). No nerve
ﬁbres (0%) could be identiﬁed in the
samples obtained by means of the linear
incision technique (Fig. 2). While the
linear incision approach permitted retrie-
val of at least ﬁve glands, punch biopsies
did not provide enough material for the
diagnosis of Sjo¨gren’s syndrome. The
results are summarized in Table 1.
Pathological analysis revealed no hand-
ling-related artefacts (pseudo-cysts, crush-
ing, fragmentation, haemorrhage, or
ﬁssures), although ﬁxing alterations could
be recognized (more appearing at the lip
mucosa epithelium and the minor salivary
glands), probably due to the use of frozen
cadaveric material.
Discussion
The selection of a particular technique for
MSGB is limited by the absence of clinical
trials and standardization of surgical com-
plications, which seriously compromise
the validity of the information available
in the literature on this topic. Existing
case series display a wide range of sample
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Fig. 1. Deep portion of a lower lip sample obtained by punch biopsy: sectioned nerve ﬁbres can
be seen close to a minor salivary gland (haematoxylin and eosin, 4).
sizes (6–502 patients), with different
frequencies of complications associated
with the variety of techniques
employed.1,4,5 Studies performing inci-
sions shorter than 2 cm with a scalpel have
reported complications ranging from none
to 9.3%,4 whereas those using larger inci-
sions (2–3 cm) have described complica-
tions in the range of 3.7–31%.7 Transient
disorders of lip sensitivity were found to
occur in up to 11.7% of the procedures,4
and those studies with follow-up periods
beyond 1 year have reported persistent
lower lip hypoaesthesia in about 3.4–4%
of the cases.4 Only minimally invasive
techniques5,6 (excluding punch), based
upon multiple 2–3-mm scalpel incisions
on the inner side of the lower lip combined
with a cup forceps to retrieve the tissue
samples, have proved the absence of neu-
rological morbidity after a follow-up per-
iod of 1.5 years.4
However, minor salivary gland punch
biopsy has been suggested as an alternative
to incisional biopsy techniques precisely
because of the absence of risk to the patient,
its simplicity (can be performed by a single
operator), and also because it is less expen-
sive.2,3 This technique consists of obtaining
the biopsy from the buccal side of the lower
lip – which is stabilized by the patient
him/herself – using a 4–5-mm punch, which
permits the retrieval of a cylinder of tissue
up to 8 mm in length2,3; no complications
have been reported using this protocol in a
series of 14 patients3 and only 4% of tran-
sient numbness in a series of 50 cases with
an unspeciﬁed follow-up period.2
Although this approach may seem inter-
esting, the percentages of undesired events
reported in these investigations2,3 should
be considered with caution, as they are
unexpectedly well under those described
for incisional techniques, where sensory
nerves can clearly be seen and subse-
quently avoided, and also because they
strongly disagree with our results obtained
under controlled experimental conditions.
In general, sample size calculations may
not be required for pilot studies, as they
are focused mainly on feasibility rather
than on statistical signiﬁcance. However,
it has to be kept in mind that studies with
small sample sizes may not disclose dif-
ferences between groups. Despite our
study being performed on a small series
of cadaveric material, the massive differ-
ences in terms of neural damage between
the two techniques disclosed by this study
seem to suggest that the chances of error
are remote, irrespective of sample size
issues. Moreover, post-mortem studies
have frequently been employed when vali-
dating glandular biopsy for the diagnosis
of SS.8 Fresh, cryopreserved (frozen)
corpses are the best model in terms of
similarity of tissue quality and surgical
handling. The age of the patients in the
series (>50 years) may also be an advan-
tage, because as persons grow older, ﬁbro-
sis and reductions of the acinar volume
occurs, which is a situation similar to that
found in SS patients.8
Previous reports have described the col-
lection of an average of six minor salivary
glands using incisional techniques of 1.5
and 2 cm.10,4,5,7 In addition, our study on
MSGB using a 1.5-cm linear incision per-
mitted retrieval of at least ﬁve glands,
whereas punch biopsy did not provide
enough gland material for the diagnosis
of SS in any situation. Incisional techni-
ques (including minimally invasive ones)
have enabled the retrieval of an average of
more than ﬁve glands accompanied by
only 1.6% of undesired material, mostly
fatty or ﬁbromuscular in nature.5 In con-
trast, sampling error is an inherent handi-
cap of punch techniques, which
sometimes require an additional biopsy
on the other side of the lip,2 thus increas-
ing morbidity. The reduction of the surgi-
cal time to a ‘‘few minutes’’2 does not
seem to be an advantage of the punch
biopsy either, as incisional biopsies using
linear incisions take from 5 to 9 min.7
Minimally invasive techniques can also
be performed within a minimal operative
time.
Alternative procedures to MSGB for the
diagnosis of SS, such as sublingual sali-
vary gland biopsy9 and parotid biopsy,10
have been found to cause no neural mor-
bidity. These comparative studies seem to
suggest that both procedures – sublingual
and parotid biopsy – retain a diagnostic
potential comparable to that of lip biopsy
and may be associated with lower post-
operative morbidity.9,10
Within the limitations of this type
of study, our results discourage the use
of punch techniques for biopsies of the
minor salivary glands in the lip and pro-
vide information on the superiority of
linear incisional biopsies in terms of
neural damage. The results of this pilot
study may promote the undertaking of
clinical trials on patients in whom Sjo¨g-
ren’s syndrome is suspected, comparing
the morbidity associated with MSGB (lin-
ear incisional technique vs. minimally
invasive) and major salivary gland biopsy.
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Fig. 2. Minor salivary gland obtained by linear incisional technique (haematoxylin and eosin,
4).
Table 1. Number of glands and presence of nerve tissue in the specimens.
Case
Age,
years Gender
Punch specimen
length (mm)
No. of glands in
each sample
Presence of nerve
tissue
Punch
Linear
incision Punch
Linear
incision
1 76 F 5.5 – 5 + 
2 72 M 7.0 1 5 + 
3 79 M 7.0 1 5 + 
4 70 F 8.5 1 5 + 
5 73 M 8.2 2 5 + 
F, female; M, male.
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Abstract
Objectives: To review the existing techniques for minor salivary gland biopsy (MSGB) in the lip and to suggest a
new approach to ease the procedure and reduce post-operative complications.
Study Design: A comprehensive literature review and a descriptive study of a new surgical technique.
Results: Diverse incisions have been suggested for MSGB with different designs (ellipse, circular, linear), different 
directions (parallel, oblique, vertical) and a wide range of lengths (from 1 mm up to 3 cm), but no comparative 
studies supporting the advantages of a particular type of incision over the others could be retrieved. A variety of 
features of the existing techniques for MSGB are linked to undesired events and surgical complications which
could be minimized by modifying certain aspects of these procedures. The technique described, together with the
use of the S forceps, represents a significant improvement over the already described chalazion forceps because it 
allows for a better access and positioning of the lower lip, improves the ergonomic conditions of the assistant, and 
facilitates the identification of lip areas with more superficial gland lobules.
Conclusions: The suggested approach for lip MSGB includes a specifically designed instrument whose performance 
during lip biopsy may contribute to minimize post-operative complications.
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Introduction
The Sjögren’s syndrome (SS) is an autoimmune exocrine
disorder with signs and symptoms of dry mouth and 
keratoconjunctivitis sicca, which may sometimes
display a wide range of systemic, non-glandular 
alterations (1,2). The prevalence of this syndrome has 
been estimated to range between 0.5% and 1% (3), with 
a female:male ratio of about 9:1 (1-3).
Histopathology in minor salivary gland (presence of 
focal lymphocytic sialadenitis with a focus score ≥1) is 
one out of the six diagnostic criteria set in the revised 
international classification for Sjögren’s Syndrome 
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Fig. 1. “S” forceps.
Fig. 2. “S” forceps in use.
(2) for diagnosis of SS. It has recently become more
important because of the consensus in considering only
objective criteria to define a SS case, which has to meet 
at least 2 of the following 3 findings: 1. Positivity serum 
anti-SSA and/or SSB; 2. Ocular staining score >3; and 3.
Presence of focal lymphocytic sialadenitis with a focus
score >1 per 4 mm2 of glandular tissue (2).
A systematic review on minor salivary gland biopsy 
(MSGB) has proved diagnostic value for SS with high
specificity (X±SD= 88.1±11.7) and sensitivity (X±SD= 
78.8±11.2), as well as diagnostic confidence in terms 
of positive (X±SD= 87.6±9.5) and negative (X±SD= 
79.0±16.9) predictive values (3). These results make this 
technique particularly useful for patients suspicious for 
SS with inconclusive clinical findings (4). MSGB may
also contribute to diagnosis of amyloidosis, sarcoidosis,
and confirmation of neonatal hemochromatosis (3,5,6).
Despite the different surgical approaches suggested for 
MSGB (use of chalazion forceps for tissue stabilization,
usage of scalpel vs. punch, different incision sizes, and 
need or not for suturing), both immediate and mediate
complications are continuously described in the
literature, being the most relevant a long-lasting lower lip 
numbness occurring in up to 6% of MSGB procedures
(7). These events support the need for a review of the
technique to reduce morbidity. In this sense, we suggest 
the use of a specifically designed forceps for lip biopsy 
in SS patients that improves tissue stabilization, eases 
the procedure, and reduces complications.
Material and Methods
The materials required for this technique include a 
syringe for intraoral local anaesthesia, scalpel with a 
No. 15 blade, non-toothed Adson forceps, 4/0 braided 
silk suture, and the “S” forceps for biopsy (OEPM nº
201200158) (Fig.1). This is a 18.5 cm long forceps with a 
fenestrated active end (5 cm2). Both the fenestrated area
(longitudinal to the axis of the forceps) and its wide size
are conceived to provide an ample surgical field. The 
non-fenestrated blade of the forceps is slightly convex 
in shape to facilitate herniation of minor salivary gland 
lobules. There is a screw in the shank for adjustment of 
the space between the blades, thus permitting a variable
and controlled pressure over the soft tissues during the
surgical procedure. The handles of the forceps are at an
angle with the blades to help traction and visibility of 
the surgical field. This angle also permits the forceps to 
work as a surgical separator improving accessibility by
means of a traction-separation movement.
Technique
The biopsy site should be selected from the inner side
of the lower lip, rich in minor salivary glands, avoiding
the midline area due to its lesser content of glandular 
component (Fig. 2).
Local anesthesia is performed by perilesional infiltration
or blockage of the mental nerve. Once anesthesia is
achieved, the whole lower lip is stabilized using the S
forceps, and the biopsy site selected taking advantage
of the forceps design which forces the gland lobules to
protrude through the fenestrated blade.
A horizontal linear incision of about 1 cm to 1.5 cm 
is performed away from the midline, combined with 
a blunt dissection of the borders of the wound. At this 
stage, the lobules are herniated towards the surface 
of the wound pushed by the non-fenestrared, convex, 
blade of the forceps (Fig. 3). Five to seven lobules can 
now be gently removed using the Adson tweezers and 
introduced into an abundant fixing solution (at least 
ten fold the volume of the tissue sampled). The wound 
is then sutured with interrupted single sutures. Use of 
magnification is recommended when performing the 
technique in order to identify superficial nerves and 
vessels and to diminish surgical morbidity.
Observations about the technique
MSGB of the lip is a key diagnostic tool for the diagnosis 
of systemic disorders and particularly of SS.
The technique described above, together with the use
of the S forceps, represents a significant improvement 
over the already described chalazion forceps because
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Fig. 3. Excision of a minor salivary gland.
Fig. 4. Minor salivary gland (H&E x10).
it allows for a better access and positioning of the 
lower lip, improves the ergonomic conditions of the 
assistant, and facilitates the identification of lip areas
with more superficial gland lobules. It also permits a
better bleeding control during surgery, an enhanced 
visualization of vessel and nerve endings, reduces the 
surgical time, and provides non-artefacted lobules for 
pathological analysis (Fig. 4).
Discussion
Techniques and complications in MSGB
Despite there is a wide agreement on avoiding the
glandular-free zone in the centre of the lower lip, it 
seems to exist a remarkable lack of standardisation of 
the MSGB technique when aimed at obtaining at least 
five glandular lobules for the diagnosis of SS (8). 
Different incisions have been suggested with different 
designs (ellipse, circular, linear), different directions
(parallel, oblique, vertical) and a wide range of lengths 
(from 1 mm up to 3 cm), but no comparative studies
supporting the advantages of a particular type of 
incision over the others could be retrieved (9-19).
Most frequent immediate surgical complications
include intra- and post-operative bleeding (9,11). Pain, 
inflammation, wound infection, suture dehiscence, and 
cheloid scars are described as mediate complications of 
glandular biopsy (7,9-15), but the so-called “disorders
of lip sensitivity” are the most frequently reported 
complication (18,19), occurring in up to 11% of cases 
in large series (12). This finding has discouraged 
the use of a punch for MSGB because it removes lip 
mucosa together with the attached gland, and favoured 
techniques that permit identification and avoidance of 
sensory nerve endings (16). These complications may
well justify that only patients in a community setting
with negative results for anti-RO/la antibodies would be 
referred for MSGB (20).
Lip stabilization devices
In this sense, some authors have suggested the use of 
chalazion forceps, employed by ophtalmologists during
chalazion exeresis, to ease biopsy of minor salivary 
gland from mobile lip tissue, as it permits tissue 
stabilization and to work under ischemic conditions 
(6,7). However, this instrument was originally designed 
for ophthalmology and has a number of shortcomings 
for oral use: the handles of the chalazion forceps are 
small-sized to allow finger control and are placed 
perpendicular to the main axis of the blades; this 
forces the assistant’s hand to work on an uncomfortable 
position, too near to the surgical field. The size of the 
fenestration also limits the incision design, particularly
when undertaking minimally invasive techniques with 
multiple 2 mm incisions along the inner face of the 
lower lip (13,18,19). An improved chalazion forceps 
was introduced by López-Jornet et al. (21): this forceps 
was larger than the original (20 cm.) and its active 
end provided a constant pressure of 1Kg/cm2 on the
tissues exerted by means of two flat plates (one of them
with a round opening, sized 1.7 cm diameter). This
design eases lip stabilization by the assistant, but it is 
impossible to graduate the pressure on the lip tissue and 
the fenestrated blade provides a reduced surgical field.
On the other hand, the forceps we suggest for MSGB, 
besides permitting a controlled pressure adapted to 
the surgical time and to the features of the lip of the 
patient (macrochelia, etc.), allows a more ergonomic 
hand grasp in such a way that keeps the assistant’s hand 
away from the working area without disturbing the 
surgeon. Moreover, the width of the fenestrated blade 
in this forceps conditions neither the design nor the size 
of the incisions as well as permits minimally invasive
techniques, where a wide surgical field is required to 
harvest glandular tissue all over th inner side of the 
lower lip  (18).
Conclusion
This forceps stabilizes lip tissues, avoids excessive 
intra-operative bleeding, permits better visibility of 
the surgical field, allows improved selection of tissue 
samples for pathological analysis and has a potential
to minimize the morbidity related to iatrogenic nerve 
lesions.
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